[{"data":1,"prerenderedAt":289},["ShallowReactive",2],{"news-list-en":3},[4,24,41,58,75,92,109,126,143,160,175,192,209,226,241,257,274],{"id":5,"date":6,"date_gmt":7,"modified":8,"modified_gmt":9,"title":10,"excerpt":12,"content":13,"featured_image":16,"categories":17,"tags":19,"sort_order":20,"focus_keyphrase":21,"seo_title":22,"seo_description":23},1408,"2026-08-09T18:19:11","2026-08-09T10:19:11","2026-08-13T14:12:39","2026-08-13T06:12:39",{"rendered":11},"Fertsy Showcases AI Healthcare Innovation at the AI×MedTech Asia Innovation Challenge in Nagoya","\u003Cp>Fertsy joined the AI×MedTech Asia Innovation Challenge in Nagoya, presenting its AI-assisted reproductive medicine technologies and exploring collaboration with leading Asian healthcare innovators.\u003C\u002Fp>\n",{"rendered":14,"protected":15},"\u003Cp class=\"wp-block-paragraph\">On August 4–5, the \u003Cstrong>AI×MedTech Asia Innovation Challenge\u003C\u002Fstrong>, jointly organized by the \u003Cstrong>Aichi Prefectural Government\u003C\u002Fstrong> and \u003Cstrong>Fujita Health University\u003C\u002Fstrong>, was held at Station Ai in Nagoya, Japan. As a major gathering for AI-driven healthcare innovation in Asia, the event brought together more than 20 companies from Japan, China, South Korea, Singapore, and other Asian markets, along with leading Japanese medical device manufacturers, distributors, academic institutions, and media organizations. Participants explored emerging trends and business opportunities at the intersection of artificial intelligence and healthcare.\u003C\u002Fp>\n\n\n\n\u003Cfigure class=\"wp-block-image size-full\">\u003Cimg loading=\"lazy\" decoding=\"async\" src=\"https:\u002F\u002Fshengshengyi.com\u002Fwp-content\u002Fuploads\u002F2026\u002F08\u002Fwechat-ar2vqt359oykmfl5vi50pvxyonw-cnxuaqw9-7gkpmh3mrml3jdfsx7ohwsx0gkw-0-image-1.webp\" alt=\"Fertsy Showcases AI Healthcare Innovation at the AI×MedTech Asia Innovation Challenge in Nagoya — Image 1\" class=\"wp-image-1215 fertsy-content-image fertsy-content-image--wide\" sizes=\"auto, (max-width: 1080px) 100vw, 1080px\" style=\"display:block;max-width:90%;width:90%;height:auto;aspect-ratio:1080 \u002F 608;object-fit:contain;margin:24px auto;\">\u003C\u002Ffigure>\n\n\n\n\u003Ch2 class=\"wp-block-heading\">A Leading Platform for AI Healthcare Innovation\u003C\u002Fh2>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">The Aichi Prefectural Government has continued to advance its AI healthcare strategy, working to establish the prefecture as a leading medical technology innovation hub in Asia. Fujita Health University, one of Japan’s leading private medical universities, is highly regarded for its work in clinical medicine, biomedical engineering, and interdisciplinary research. By bringing government and academia together, the event provided Asian AI healthcare companies with a high-level platform for presentation and exchange while creating an important bridge between technological innovation and real-world adoption. Leaders from both organizing institutions attended the conference and delivered remarks.\u003C\u002Fp>\n\n\n\n\u003Cfigure class=\"wp-block-image size-full\">\u003Cimg loading=\"lazy\" decoding=\"async\" src=\"https:\u002F\u002Fshengshengyi.com\u002Fwp-content\u002Fuploads\u002F2026\u002F08\u002Fwechat-ar2vqt359oykmfl5vi50pvxyonw-cnxuaqw9-7gkpmh3mrml3jdfsx7ohwsx0gkw-0-image-2.webp\" alt=\"Fertsy Showcases AI Healthcare Innovation at the AI×MedTech Asia Innovation Challenge in Nagoya — Image 2\" class=\"wp-image-1216 fertsy-content-image fertsy-content-image--wide\" sizes=\"auto, (max-width: 1080px) 100vw, 1080px\" style=\"display:block;max-width:90%;width:90%;height:auto;aspect-ratio:1080 \u002F 1064;object-fit:contain;margin:24px auto;\">\u003C\u002Ffigure>\n\n\n\n\u003Ch2 class=\"wp-block-heading\">Fertsy Represents China’s AI Healthcare Innovators\u003C\u002Fh2>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Fertsy Inc was invited to participate as a representative of China’s AI healthcare sector. Fertsy delivered a presentation introducing its technology portfolio in AI-assisted reproductive medicine, its international product strategy, and its latest progress in the Japanese market.\u003C\u002Fp>\n\n\n\n\u003Cfigure class=\"wp-block-image size-full\">\u003Cimg loading=\"lazy\" decoding=\"async\" src=\"https:\u002F\u002Fshengshengyi.com\u002Fwp-content\u002Fuploads\u002F2026\u002F08\u002Fwechat-ar2vqt359oykmfl5vi50pvxyonw-cnxuaqw9-7gkpmh3mrml3jdfsx7ohwsx0gkw-0-image-3.webp\" alt=\"Fertsy Showcases AI Healthcare Innovation at the AI×MedTech Asia Innovation Challenge in Nagoya — Image 3\" class=\"wp-image-1217 fertsy-content-image fertsy-content-image--wide\" sizes=\"auto, (max-width: 1080px) 100vw, 1080px\" style=\"display:block;max-width:90%;width:90%;height:auto;aspect-ratio:1080 \u002F 810;object-fit:contain;margin:24px auto;\">\u003C\u002Ffigure>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">During the event, the Fertsy team held a series of in-depth one-on-one meetings with Fujita Health University, major Japanese medical device manufacturers, and local distributors. The discussions covered technology partnerships, product implementation, market access, and channel development, with the aim of identifying practical paths for China–Japan collaboration in AI healthcare.\u003C\u002Fp>\n\n\n\n\u003Cfigure class=\"wp-block-image size-large\">\u003Cimg loading=\"lazy\" decoding=\"async\" src=\"https:\u002F\u002Fshengshengyi.com\u002Fwp-content\u002Fuploads\u002F2026\u002F08\u002Fwechat-ar2vqt359oykmfl5vi50pvxyonw-cnxuaqw9-7gkpmh3mrml3jdfsx7ohwsx0gkw-0-image-4-1024x692.webp\" alt=\"Fertsy Showcases AI Healthcare Innovation at the AI×MedTech Asia Innovation Challenge in Nagoya — Image 4\" class=\"wp-image-1218 fertsy-content-image fertsy-content-image--wide\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" style=\"display:block;max-width:90%;width:90%;height:auto;aspect-ratio:1024 \u002F 692;object-fit:contain;margin:24px auto;\">\u003C\u002Ffigure>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">A Fertsy representative was also interviewed by NNA, a leading Asian business news organization, and shared perspectives on the development of China’s AI healthcare industry, the company’s approach to technological innovation, and its international growth strategy.\u003C\u002Fp>\n\n\n\n\u003Ch2 class=\"wp-block-heading\">Deepening Fertsy’s Presence in Asia Through Cross-Border Collaboration\u003C\u002Fh2>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">The visit to Nagoya marked another important step in Fertsy’s expansion across Asia. Through direct dialogue with a leading Japanese medical university, established industry players, and professional media, the company gained further insight into the potential applications of AI healthcare technologies in Japan and the opportunities for future collaboration.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Fertsy will continue to embrace open collaboration, take part in leading international industry exchanges, and bring independently developed Chinese AI healthcare technologies to a broader global market—contributing practical solutions to the intelligent transformation of healthcare worldwide.\u003C\u002Fp>\n\n\n\n\u003Cfigure class=\"wp-block-image size-full\">\u003Cimg loading=\"lazy\" decoding=\"async\" src=\"https:\u002F\u002Fshengshengyi.com\u002Fwp-content\u002Fuploads\u002F2026\u002F08\u002Fwechat-ar2vqt359oykmfl5vi50pvxyonw-cnxuaqw9-7gkpmh3mrml3jdfsx7ohwsx0gkw-0-image-5.webp\" alt=\"Fertsy Showcases AI Healthcare Innovation at the AI×MedTech Asia Innovation Challenge in Nagoya — Image 5\" class=\"wp-image-1219 fertsy-content-image fertsy-content-image--wide\" sizes=\"auto, (max-width: 1080px) 100vw, 1080px\" style=\"display:block;max-width:90%;width:90%;height:auto;aspect-ratio:1080 \u002F 821;object-fit:contain;margin:24px auto;\">\u003C\u002Ffigure>",false,"https:\u002F\u002Fshengshengyi.com\u002Fwp-content\u002Fuploads\u002F2026\u002F08\u002Fwechat-ar2vqt359oykmfl5vi50pvxyonw-cnxuaqw9-7gkpmh3mrml3jdfsx7ohwsx0gkw-0-cover.jpg",[18],3,[],0,"AI healthcare innovation","AI Healthcare Innovation in Nagoya | Fertsy","Explore Fertsy’s AI healthcare innovation at the AI×MedTech Asia Innovation Challenge in Nagoya and its progress in assisted reproductive medicine.",{"id":25,"date":26,"date_gmt":27,"modified":28,"modified_gmt":29,"title":30,"excerpt":32,"content":33,"featured_image":35,"categories":36,"tags":37,"sort_order":20,"focus_keyphrase":38,"seo_title":39,"seo_description":40},1231,"2026-07-15T18:17:01","2026-07-15T10:17:01","2026-08-13T15:01:35","2026-08-13T07:01:35",{"rendered":31},"ESHRE 2026 Successfully Concludes | Advancing International Market Expansion","\u003Cp>From July 5 to 8, the largest and most influential annual event in reproductive medicine, the European Society of Human Reproduction and Embryology (ESHRE) Annual Meeting, was held in London. As a bellwether for new tech\u003C\u002Fp>\n",{"rendered":34,"protected":15},"\u003Cp class=\"wp-block-paragraph\">From July 5 to 8, the largest and most influential annual event in reproductive medicine, the European Society of Human Reproduction and Embryology (ESHRE) Annual Meeting, was held in London. As a bellwether for new technologies and products in global assisted reproduction, this meeting attracted tens of thousands of doctors, embryologists, and industry professionals from over a hundred countries.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Fertsy exhibited its core products and latest research achievements, receiving better-than-expected market feedback during the four-day event.\u003C\u002Fp>\n\n\n\n\u003Cfigure class=\"wp-block-image size-full\">\u003Cimg decoding=\"async\" class=\"rich_pages wxw-img fertsy-content-image fertsy-content-image--wide\" data-aistatus=\"1\" data-backh=\"407\" data-backw=\"425\" data-imgfileid=\"100000903\" data-ratio=\"0.9569313593539704\" data-src=\"https:\u002F\u002Fshengshengyi.com\u002Fwp-content\u002Fuploads\u002F2026\u002F07\u002Fwechat-wechat-link-1527ad0827575602d170e30f-0-image-1.jpg\" data-type=\"jpeg\" data-w=\"743\" style=\"display:block;max-width:90%;width:90%;height:auto;aspect-ratio:1 \u002F 0.956931;object-fit:contain;margin:24px auto;\" src=\"https:\u002F\u002Fshengshengyi.com\u002Fwp-content\u002Fuploads\u002F2026\u002F07\u002Fwechat-wechat-link-1527ad0827575602d170e30f-0-image-1.jpg\">\u003C\u002Ffigure>\n\n\n\n\u003Ch2 class=\"wp-block-heading\">Core product EmbryoInsights™ became the focus, with sustained high foot traffic at the booth.\u003C\u002Fh2>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">During the exhibition, the EmbryoInsights AI embryo assessment system, leveraging its stable performance and proven maturity in real-world clinical applications, drew agents and fertility center representatives from Europe, the Middle East, Southeast Asia, Latin America, and beyond for discussions and collaboration.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Many loyal clients visited specifically to share their user experiences. A large number of prospective clients expressed clear interest after reviewing detailed product specifications and partnership models on site. The system’s vivid and rich visual effects also turned our booth into a photo hotspot, briefly becoming one of the exhibition’s most popular check-in spots.\u003C\u002Fp>\n\n\n\n\u003Cfigure class=\"wp-block-image size-full\">\u003Cimg decoding=\"async\" class=\"rich_pages wxw-img fertsy-content-image fertsy-content-image--wide\" data-aistatus=\"1\" data-backh=\"228\" data-backw=\"351\" data-imgfileid=\"100000902\" data-ratio=\"0.6504065040650406\" data-src=\"https:\u002F\u002Fshengshengyi.com\u002Fwp-content\u002Fuploads\u002F2026\u002F07\u002Fwechat-wechat-link-1527ad0827575602d170e30f-0-image-2.jpg\" data-type=\"jpeg\" data-w=\"615\" style=\"display:block;max-width:90%;width:90%;height:auto;aspect-ratio:1 \u002F 0.650407;object-fit:contain;margin:24px auto;\" src=\"https:\u002F\u002Fshengshengyi.com\u002Fwp-content\u002Fuploads\u002F2026\u002F07\u002Fwechat-wechat-link-1527ad0827575602d170e30f-0-image-2.jpg\">\u003C\u002Ffigure>\n\n\n\n\u003Ch2 class=\"wp-block-heading\">New Product Debuts, Sparking Heated Discussion on Innovative Concept\u003C\u002Fh2>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">At this exhibition, we unveiled the EmbryoNest intelligent culture system prototype and the IV-Flow fertility center large model system to the world for the first time. These two concept products immediately attracted widespread attention. Experts and peers from various countries engaged in in-depth exchanges with our team, expressing unanimous hope for swift regulatory approval and market launch. We also gathered many valuable insights and feedback.\u003C\u002Fp>\n\n\n\n\u003Cfigure class=\"wp-block-image size-full\">\u003Cimg decoding=\"async\" class=\"rich_pages wxw-img fertsy-content-image fertsy-content-image--wide\" data-aistatus=\"1\" data-backh=\"255\" data-backw=\"340\" data-imgfileid=\"100000904\" data-ratio=\"0.75\" data-src=\"https:\u002F\u002Fshengshengyi.com\u002Fwp-content\u002Fuploads\u002F2026\u002F07\u002Fwechat-wechat-link-1527ad0827575602d170e30f-0-image-3.jpg\" data-type=\"png\" data-w=\"664\" style=\"display:block;max-width:90%;width:90%;height:auto;aspect-ratio:1 \u002F 0.75;object-fit:contain;margin:24px auto;\" src=\"https:\u002F\u002Fshengshengyi.com\u002Fwp-content\u002Fuploads\u002F2026\u002F07\u002Fwechat-wechat-link-1527ad0827575602d170e30f-0-image-3.jpg\">\u003C\u002Ffigure>\n\n\n\n\u003Ch2 class=\"wp-block-heading\">Extensive International Collaborations Underway\u003C\u002Fh2>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">The exhibition also served as a stage for advancing our broad international strategy and technical collaborations. We held multiple cooperation discussions with the management teams of several large fertility center chains, solidifying cooperation objectives for the next phase. We also conducted technical exchanges with many emerging European and American imaging technology manufacturers exhibiting at the event, exploring potential areas for future joint collaboration.\u003C\u002Fp>\n\n\n\n\u003Ch2 class=\"wp-block-heading\">From the Exhibition to the Market: Further Advancing International Expansion\u003C\u002Fh2>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Through this exhibition, the Fertsy brand’s visibility in the international market further increased, yielding a wealth of sales leads and partnership inquiries, while also bringing back valuable expert feedback. Although the exhibition has concluded, the real work of acting on these leads, feedback, and new ideas is just beginning.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Thank you to every customer and partner who visited our booth, and to every colleague on the team for their efforts. The road ahead, we continue together.\u003C\u002Fp>\n\n\n\n\u003Cfigure class=\"wp-block-image size-full\">\u003Cimg decoding=\"async\" class=\"rich_pages wxw-img fertsy-content-image fertsy-content-image--wide\" data-aistatus=\"1\" data-backh=\"224\" data-backw=\"298\" data-imgfileid=\"100000905\" data-ratio=\"0.7511111111111111\" data-src=\"https:\u002F\u002Fshengshengyi.com\u002Fwp-content\u002Fuploads\u002F2026\u002F07\u002Fwechat-wechat-link-1527ad0827575602d170e30f-0-image-4.jpg\" data-type=\"jpeg\" data-w=\"675\" style=\"display:block;max-width:90%;width:90%;height:auto;aspect-ratio:1 \u002F 0.751111;object-fit:contain;margin:24px auto;\" src=\"https:\u002F\u002Fshengshengyi.com\u002Fwp-content\u002Fuploads\u002F2026\u002F07\u002Fwechat-wechat-link-1527ad0827575602d170e30f-0-image-4.jpg\">\u003C\u002Ffigure>","https:\u002F\u002Fshengshengyi.com\u002Fwp-content\u002Fuploads\u002F2026\u002F07\u002Fwechat-wechat-link-1527ad0827575602d170e30f-0-cover.jpg",[18],[],"ESHRE 2026 Successfully Concludes ","ESHRE 2026 | Fertsy","ESHRE 2026: discover key developments, clinical context, and Fertsy’s progress in AI-assisted reproduction, IVF technology, and healthcare innovation.",{"id":42,"date":43,"date_gmt":44,"modified":45,"modified_gmt":46,"title":47,"excerpt":49,"content":50,"featured_image":52,"categories":53,"tags":54,"sort_order":20,"focus_keyphrase":55,"seo_title":56,"seo_description":57},882,"2026-04-30T10:17:12","2026-04-30T02:17:12","2026-08-13T14:51:47","2026-08-13T06:51:47",{"rendered":48},"Fertsy Successfully Obtains Its First FDA 510(k) Clearance","\u003Cp>Recently, Fertsy’s self-developed negative pressure oocyte retrieval pump (model: AD-VPUM-500) officially received U.S. Food and Drug Administration (FDA) 510(k) clearance, officially gaining market access in the United \u003C\u002Fp>\n",{"rendered":51,"protected":15},"\u003Cp class=\"wp-block-paragraph\">Recently, Fertsy’s self-developed negative-pressure oocyte retrieval pump (model: AD-VPUM-500) received U.S. Food and Drug Administration (FDA) 510(k) clearance, securing market access in the United States.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">This is Fertsy’s first FDA 510(k) clearance and the company’s first cleared active medical device. This milestone demonstrates that the product’s quality, safety, and compliance meet leading global standards, providing an “international passport” to the global market.\u003C\u002Fp>\n\n\n\n\u003Cfigure class=\"wp-block-image size-full is-resized is-style-rounded\">\u003Cimg loading=\"lazy\" decoding=\"async\" src=\"https:\u002F\u002Fshengshengyi.com\u002Fwp-content\u002Fuploads\u002F2026\u002F04\u002F%E5%BE%AE%E4%BF%A1%E5%9B%BE%E7%89%87_20260429162712_397_328-1.png\" alt=\"\" class=\"wp-image-781 fertsy-content-image fertsy-content-image--wide\" style=\"display:block;max-width:90%;width:90%;height:auto;aspect-ratio:696 \u002F 356;object-fit:contain;margin:24px auto;\" sizes=\"auto, (max-width: 696px) 100vw, 696px\">\u003C\u002Ffigure>\n\n\n\n\u003Ch2 class=\"wp-block-heading\">1. Core Technological Advantages: Ensuring Oocyte Safety\u003C\u002Fh2>\n\u003Cp class=\"wp-block-paragraph\">The negative-pressure oocyte retrieval pump is primarily used in assisted reproduction technology (ART) procedures to aspirate oocytes through low-flow, intermittent negative pressure. Addressing clinical requirements for stability and control, the device has been systematically optimized for negative pressure accuracy, response control, and user experience, providing fertility centers with safer and more reliable equipment support.\u003C\u002Fp>\n\n\n\n\u003Cdiv class=\"wp-block-media-text is-stacked-on-mobile\">\u003Cfigure class=\"wp-block-media-text__media\">\u003Cimg loading=\"lazy\" decoding=\"async\" src=\"https:\u002F\u002Fshengshengyi.com\u002Fwp-content\u002Fuploads\u002F2026\u002F04\u002Fpump-1024x539.png\" alt=\"\" class=\"wp-image-777 size-full fertsy-content-image fertsy-content-image--wide\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" style=\"display:block;max-width:90%;width:90%;height:auto;aspect-ratio:1024 \u002F 539;object-fit:contain;margin:24px auto;\">\u003C\u002Ffigure>\u003Cdiv class=\"wp-block-media-text__content\">\n\u003Cp class=\"wp-block-paragraph\">Intelligent algorithm controls negative pressure output with adaptive regulation of pressure changes, reducing fluctuation interference for a smoother and more controllable aspiration process. Low-noise operation design ensures the device runs quietly and smoothly, minimizing operational interference and enhancing clinical focus. Sustained stable negative pressure performance maintains consistent output across different operation stages, reducing uncertainty from manual adjustments.\u003C\u002Fp>\n\u003C\u002Fdiv>\u003C\u002Fdiv>\n\n\n\n\u003Ch2 class=\"wp-block-heading\">2. Human-Centered Design for More Efficient Operation\u003C\u002Fh2>\n\n\n\n\u003Cdiv class=\"wp-block-media-text is-stacked-on-mobile\">\u003Cfigure class=\"wp-block-media-text__media\">\u003Cimg loading=\"lazy\" decoding=\"async\" src=\"https:\u002F\u002Fshengshengyi.com\u002Fwp-content\u002Fuploads\u002F2026\u002F04\u002FVacuum_pump_03-1024x706.png\" alt=\"\" class=\"wp-image-778 size-full fertsy-content-image fertsy-content-image--wide\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" style=\"display:block;max-width:90%;width:90%;height:auto;aspect-ratio:1024 \u002F 706;object-fit:contain;margin:24px auto;\">\u003C\u002Ffigure>\u003Cdiv class=\"wp-block-media-text__content\">\n\u003Cp class=\"wp-block-paragraph\">Knob-based adjustment provides intuitive operation and rapid response, reducing the learning curve. Foot control mode supports hands-free operation, improving procedural continuity and efficiency. Adjustable prompt feedback allows volume customization, ensuring information delivery while minimizing environmental interference.\u003C\u002Fp>\n\u003C\u002Fdiv>\u003C\u002Fdiv>\n\n\n\n\u003Ch2 class=\"wp-block-heading\">3. Full Alignment with International Regulatory Standards\u003C\u002Fh2>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">The U.S. Food and Drug Administration (FDA) is globally recognized as one of the most rigorous and authoritative medical regulatory agencies, with extensive influence worldwide. Its regulatory system is referenced or adopted by nearly 200 countries and regions.\u003C\u002Fp>\n\n\n\u003Cp class=\"wp-block-paragraph\">Obtaining FDA 510(k) clearance not only helps rapidly open the core North American market but also significantly enhances the efficiency and recognition of product registration in other international markets, providing crucial support for global business expansion. For medical devices, FDA registration means:\u003C\u002Fp>\n\n\n\n\u003Cul class=\"wp-block-list fertsy-check-list\">\u003Cli>Product safety and effectiveness are scientifically validated.\u003C\u002Fli>\u003Cli>The manufacturing system complies with QSR 820 quality system requirements.\u003C\u002Fli>\u003Cli>The entire process—from R&D and manufacturing to quality control—meets the world-class regulatory standards set by the U.S. Food and Drug Administration.\u003C\u002Fli>\u003C\u002Ful>\n\n\n\n\u003Ch2 class=\"wp-block-heading\">4. Continuous Innovation: Advancing into Broader Global Markets\u003C\u002Fh2>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Fertsy always adheres to the development philosophy of ‘Innovation, Quality, Compliance,’ focusing on providing safer, more efficient, and reliable medical device products and solutions for the global reproductive medicine field.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">In the future, the company will continue to be guided by international standards, continuously enhance its technical strength and product competitiveness, accelerate its global expansion, and serve more medical institutions and patients.\u003C\u002Fp>\n\n\n\n\u003Cblockquote class=\"wp-block-quote fertsy-article-callout\">\u003Cp>Certification is the starting point; quality is timeless.\u003C\u002Fp>\u003C\u002Fblockquote>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Fertsy will continue to take professionalism and quality as its cornerstones, advancing Chinese medical devices onto a broader world stage.\u003C\u002Fp>","https:\u002F\u002Fshengshengyi.com\u002Fwp-content\u002Fuploads\u002F2026\u002F04\u002FChatGPT-Image-2026年4月29日-19_36_59.png",[18],[],"FDA 510(k) clearance","FDA 510(k) clearance | Fertsy","Recently, Fertsy’s self-developed negative pressure oocyte retrieval pump (model: AD-VPUM-500) officially received U.S. Food and Drug Administration (FDA)…",{"id":59,"date":60,"date_gmt":61,"modified":62,"modified_gmt":63,"title":64,"excerpt":66,"content":67,"featured_image":69,"categories":70,"tags":71,"sort_order":20,"focus_keyphrase":72,"seo_title":73,"seo_description":74},883,"2025-12-31T19:44:43","2025-12-31T11:44:43","2026-08-13T14:26:09","2026-08-13T06:26:09",{"rendered":65},"Fertsy Successfully Achieves ISO 13485 International Certification","\u003Cp>Fertsy Inc today announced that its medical device soft … \u003Ca title=\"Fertsy Successfully Achieves ISO 13485 International Certification\" class=\"read-more\" href=\"http:\u002F\u002F111.229.245.165\u002F2025\u002F12\u002F31\u002Fwechat-wechat-link-87fb9cf2e4c5e7716e563fe4-0-en\u002F\" aria-label=\"阅读 Fertsy Successfully Achieves ISO 13485 International Certification\">阅读更多\u003C\u002Fa>\u003C\u002Fp>\n",{"rendered":68,"protected":15},"\u003Cfigure class=\"wp-block-image size-full\">\u003Cimg loading=\"lazy\" decoding=\"async\" src=\"https:\u002F\u002Fshengshengyi.com\u002Fwp-content\u002Fuploads\u002F2025\u002F12\u002Fimage-1024x428.jpg\" alt=\"\" class=\"wp-image-638 fertsy-content-image fertsy-content-image--wide\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" style=\"display:block;max-width:90%;width:90%;height:auto;aspect-ratio:1024 \u002F 428;object-fit:contain;margin:24px auto;\">\u003C\u002Ffigure>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Fertsy Inc today announced that its medical device software products and active medical device equipment R&D, production, and sales system has successfully passed comprehensive ISO 13485:2016 quality management system certification by SGS.\u003C\u002Fp>\n\n\n\n\u003Cfigure class=\"wp-block-image size-full\">\u003Cimg loading=\"lazy\" decoding=\"async\" src=\"https:\u002F\u002Fshengshengyi.com\u002Fwp-content\u002Fuploads\u002F2025\u002F12\u002Fimage-edited.jpeg\" alt=\"\" class=\"wp-image-639 fertsy-content-image fertsy-content-image--wide\" sizes=\"auto, (max-width: 696px) 100vw, 696px\" style=\"display:block;max-width:90%;width:90%;height:auto;aspect-ratio:696 \u002F 392;object-fit:contain;margin:24px auto;\">\u003C\u002Ffigure>\n\n\n\n\u003Ch2 class=\"wp-block-heading\">\u003Cstrong>SGS Certification: The “Hard Currency” of the Global Market\u003C\u002Fstrong>\u003C\u002Fh2>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">As a global leader in inspection, testing, and certification services, SGS is a European Union Notified Body (NB 0120). Its ISO 13485 certificates are accredited by the United Kingdom Accreditation Service (UKAS) and hold mutual recognition in more than 140 countries and regions worldwide. This certification is not only a core market access requirement for products entering major markets such as the EU, U.S. FDA, and Canada, but also a key pillar of the Medical Device Single Audit Program (MDSAP).\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Fertsy Technology’s selection of SGS is a deliberate choice to measure itself against the highest international benchmarks. This SGS certification conclusively proves that the company’s quality management system complies with the most rigorous international regulatory requirements, significantly bolstering the trustworthiness and competitive edge of its products in global supply chains, and establishing a solid foundation for its accelerated global expansion.\u003C\u002Fp>","https:\u002F\u002Fshengshengyi.com\u002Fwp-content\u002Fuploads\u002F2025\u002F12\u002Fimage.jpg",[18],[],"Fertsy Successfully Achieves ISO 13485 International","Fertsy Successfully Achieves ISO 13485 | Fertsy","Fertsy Successfully Achieves ISO 13485 International: explore the clinical context, key developments, and Fertsy’s work in AI-assisted reproduction and IV…",{"id":76,"date":77,"date_gmt":78,"modified":79,"modified_gmt":80,"title":81,"excerpt":83,"content":84,"featured_image":86,"categories":87,"tags":88,"sort_order":20,"focus_keyphrase":89,"seo_title":90,"seo_description":91},1369,"2025-09-04T21:20:00","2025-09-04T13:20:00","2026-08-13T14:35:39","2026-08-13T06:35:39",{"rendered":82},"Fertsy Products Exhibited at the Taiwan Reproductive Medicine Annual Meeting","\u003Cp>At the Taiwan Reproductive Medicine Annual Meeting exhibition, the booth of Fertsy’s distributor was bustling with visitors. Early user feedback has been received, and we look forward to continuous rapid product iteratio\u003C\u002Fp>\n",{"rendered":85,"protected":15},"\u003Cp class=\"wp-block-paragraph\">At the Taiwan Reproductive Medicine Annual Meeting exhibition, the booth of Fertsy’s distributor was bustling with visitors. We have already received initial user feedback and look forward to continuing rapid product improvements.\u003C\u002Fp>\n\n\n\n\u003Cfigure class=\"wp-block-image size-full\">\u003Cimg loading=\"lazy\" decoding=\"async\" src=\"https:\u002F\u002Fshengshengyi.com\u002Fwp-content\u002Fuploads\u002F2025\u002F10\u002F%E5%BE%AE%E4%BF%A1%E5%9B%BE%E7%89%87_2025-10-19_211930_302-edited.jpg\" alt=\"\" class=\"wp-image-488 fertsy-content-image fertsy-content-image--wide\" sizes=\"auto, (max-width: 566px) 100vw, 566px\" style=\"display:block;max-width:90%;width:90%;height:auto;aspect-ratio:566 \u002F 1006;object-fit:contain;margin:24px auto;\">\u003C\u002Ffigure>","https:\u002F\u002Fshengshengyi.com\u002Fwp-content\u002Fuploads\u002F2025\u002F10\u002F微信图片_2025-10-19_211930_302.jpg",[18],[],"reproductive medicine","reproductive medicine | Fertsy","At the Taiwan Reproductive Medicine Annual Meeting exhibition, the booth of Fertsy’s distributor was bustling with visitors. Early user feedback has been…",{"id":93,"date":94,"date_gmt":95,"modified":96,"modified_gmt":97,"title":98,"excerpt":100,"content":101,"featured_image":103,"categories":104,"tags":105,"sort_order":20,"focus_keyphrase":106,"seo_title":107,"seo_description":108},1240,"2025-08-28T21:14:00","2025-08-28T13:14:00","2026-08-13T14:36:15","2026-08-13T06:36:15",{"rendered":99},"Fertsy and Jinxin Sign Strategic Cooperation Agreement to Advance the Deployment of AI in Assisted Reproduction","\u003Cp>On August 28, 2025, Fertsy Inc (hereinafter “Fertsy”),  … \u003Ca title=\"Fertsy and Jinxin Sign Strategic Cooperation Agreement to Advance the Deployment of AI in Assisted Reproduction\" class=\"read-more\" href=\"http:\u002F\u002F111.229.245.165\u002F2025\u002F08\u002F28\u002Fwechat-wechat-link-95ad603ac6f7b37542603cdc-0-en\u002F\" aria-label=\"阅读 Fertsy and Jinxin Sign Strategic Cooperation Agreement to Advance the Deployment of AI in Assisted Reproduction\">阅读更多\u003C\u002Fa>\u003C\u002Fp>\n",{"rendered":102,"protected":15},"\u003Cp class=\"wp-block-paragraph\">On August 28, 2025, Fertsy Inc (hereinafter “Fertsy”), Chengdu Jinxin Information Technology Co., Ltd. (hereinafter “Jinxin Technology”), and Sichuan Jinxin Xinan Women’s and Children’s Hospital (hereinafter “Jinxin Xinan”) formally signed a strategic cooperation agreement in Chengdu. The three parties will engage in comprehensive cooperation on the deep application of artificial intelligence in assisted reproduction, jointly promoting the intelligent development of embryo laboratories and the improvement of clinical success rates.\u003C\u002Fp>\n\n\n\n\u003Cfigure class=\"wp-block-image size-full\">\u003Cimg decoding=\"async\" src=\"https:\u002F\u002Fshengshengyi.com\u002Fwp-content\u002Fuploads\u002F2025\u002F10\u002F%E5%BE%AE%E4%BF%A1%E5%9B%BE%E7%89%87_2025-10-19_211358_624-1024x677.jpg\" alt=\"\" class=\"wp-image-482 fertsy-content-image fertsy-content-image--wide\" style=\"display:block;max-width:90%;width:90%;height:auto;aspect-ratio:1024 \u002F 677;object-fit:contain;margin:24px auto;\">\u003C\u002Ffigure>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Laboratory Director Meng Xiangqian of Jinxin Xinan Women’s and Children’s Hospital (center), General Manager Wang Weipeng of Jinxin Technology (right), and Deputy General Manager Huang Haosi of Fertsy (left) jointly sign the strategic cooperation agreement between Fertsy and Jinxin.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Fertsy is an internationally leading startup dedicated to artificial intelligence in assisted reproduction, founded by AI and information systems experts who graduated from the Department of Electronic Engineering at Tsinghua University and have worked for many years at globally renowned companies such as Huawei, Microsoft, and Baidu. In collaboration with top-tier assisted reproduction physician teams at home and abroad, Fertsy has jointly developed a series of AI-powered embryo assessment and laboratory quality control software and hardware systems, committed to using technological innovation to improve the success rate and accessibility of assisted reproduction while reducing error rates.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Jinxin Reproductive Group (01951.HK) is committed to building an internationally leading comprehensive assisted reproduction service system. In 2021, it incubated Jinxin Technology as a key information technology platform to deepen the R&D and application transformation of core assisted reproduction technologies. Leveraging the Group’s extensive clinical and laboratory resources at home and abroad, and using Jinxin Xinan Hospital (Bisheng Campus) as the product incubation base hospital, Jinxin Technology continuously promotes the standardization, intelligentization, and internationalization of reproductive medicine technology through information technology. Its self-developed digital products and integrated solutions—including the EMR obstetrics and assisted reproduction electronic medical record system, the HSCRM medical customer service operation system, and the women’s health and fertility AI agent—have been widely adopted by dozens of medical institutions both domestically and internationally.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">According to the agreement, Fertsy and Jinxin Technology will conduct joint R&D and clinical validation at the Jinxin Xinan embryo laboratory. The collaboration covers multiple areas, including the application of artificial intelligence in embryo screening, laboratory quality control management, and intelligent workflow management. The three parties will fully leverage their respective technological, clinical, and resource advantages to accelerate the clinical translation of research outcomes, delivering assisted reproduction medical solutions with higher success rates, greater safety, and enhanced personalization to patients.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Zhang Dan, Founder and CEO of Fertsy, said: “Jinxin’s technological R&D capabilities and clinical translation experience in assisted reproduction provide an excellent platform for applying artificial intelligence in real-world scenarios. This collaboration is an important step in moving our AI technology from the lab to the clinic.”\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Director Meng Xiangqian of the Jinxin Xinan IVF Laboratory expressed great anticipation for this collaboration: “Screening for embryonic developmental potential plays a decisive role in achieving successful live births for patients. With the strong support of Professor Li Yuan, president of the hospital, the Jinxin Xinan IVF Laboratory is joining hands with Fertsy and Jinxin Technology. Through an AI-powered intelligent scoring system, we will closely connect clinical embryologists and clinicians in the IVF laboratory, empowering embryologists and helping more families realize their dreams of having a child.”\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Wang Weipeng, General Manager of Jinxin Technology, noted: “We are highly focused on the potential of artificial intelligence in medical applications. Our collaboration with Fertsy will help us achieve higher precision and controllability in every link of the IVF laboratory process, enhance the embryo selection capabilities of Jinxin’s reproductive centers, and bring hope to more families seeking to have children.”\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">The conclusion of this strategic partnership not only marks a new stage of technological synergy between Fertsy and Jinxin in the field of assisted reproduction, but also sets a benchmark for the deep integration of ‘AI + reproductive medicine’ in the industry.\u003C\u002Fp>","https:\u002F\u002Fshengshengyi.com\u002Fwp-content\u002Fuploads\u002F2025\u002F10\u002F微信图片_2025-10-19_211358_624.jpg",[18],[],"AI in assisted reproduction","Fertsy and Jinxin Sign Strategic | Fertsy","AI in assisted reproduction: explore the clinical context, key developments, and Fertsy’s work in AI-assisted reproduction and IVF technology.",{"id":110,"date":111,"date_gmt":112,"modified":113,"modified_gmt":114,"title":115,"excerpt":117,"content":118,"featured_image":120,"categories":121,"tags":122,"sort_order":20,"focus_keyphrase":123,"seo_title":124,"seo_description":125},368,"2025-08-13T20:19:46","2025-08-13T12:19:46","2026-08-13T14:50:50","2026-08-13T06:50:50",{"rendered":116},"Fertsy’s Quality Management System for Application Software Development Obtains ISO 9001 Certification","\u003Cp>Fertsy reached another significant milestone—its softwa … \u003Ca title=\"Fertsy’s Quality Management System for Application Software Development Obtains ISO 9001 Certification\" class=\"read-more\" href=\"http:\u002F\u002F111.229.245.165\u002F2025\u002F08\u002F13\u002Fsoftware-development-obtains-iso-9001-certification\u002F\" aria-label=\"阅读 Fertsy’s Quality Management System for Application Software Development Obtains ISO 9001 Certification\">阅读更多\u003C\u002Fa>\u003C\u002Fp>\n",{"rendered":119,"protected":15},"\u003Cp class=\"wp-block-paragraph\">Fertsy reached another significant milestone—its software development quality management system has successfully passed the internationally recognized GB\u002FT 19001-2016 \u002F ISO 9001:2015 quality management system certification! This achievement not only serves as authoritative recognition of the exceptional quality of software such as the EmbryoInsights™ AI embryo assessment system, but also as strong proof that Fertsy’s R&D and service processes have reached world-class standards.\u003C\u002Fp>\n\n\n\u003Cfigure class=\"aligncenter size-full is-resized wp-block-image\">\u003Cimg loading=\"lazy\" decoding=\"async\" src=\"https:\u002F\u002Fshengshengyi.com\u002Fwp-content\u002Fuploads\u002F2025\u002F08\u002F%E8%BD%AF%E4%BB%B6ISO9001-EN.png\" alt=\"\" class=\"wp-image-371 fertsy-content-image fertsy-content-image--wide\" style=\"display:block;max-width:90%;width:90%;height:auto;aspect-ratio:560 \u002F 797;object-fit:contain;margin:24px auto;\" sizes=\"auto, (max-width: 560px) 100vw, 560px\">\u003C\u002Ffigure>\n\n\n\u003Cp class=\"wp-block-paragraph\">As a cutting-edge assisted reproduction software tool deeply integrated with artificial intelligence, the ISO 9001 certification of the development quality management system behind EmbryoInsights™ and other software systems reflects its rigorous quality assurance in the following core areas:\u003C\u002Fp>\n\n\n\n\u003Ch2 class=\"wp-block-heading\">Reliable Assessment\u003C\u002Fh2>\n\n\n\u003Cp class=\"wp-block-paragraph\">The certification ensures that algorithm development, model training, and validation processes are highly standardized, delivering stable and trustworthy outputs that provide solid data support for optimal embryo selection.\u003C\u002Fp>\n\n\n\n\u003Ch2 class=\"wp-block-heading\">Standardized Processes\u003C\u002Fh2>\n\n\n\u003Cp class=\"wp-block-paragraph\">From requirements analysis, software development, and system testing to user training and ongoing maintenance, every stage strictly follows international quality management standards.\u003C\u002Fp>\n\n\n\n\u003Ch2 class=\"wp-block-heading\">User Assurance\u003C\u002Fh2>\n\n\n\u003Cp class=\"wp-block-paragraph\">A continuous improvement mechanism ensures the system can accurately respond to the core needs of reproductive centers worldwide, delivering efficient, stable, and reliable technical support.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Achieving ISO 9001 certification means that Fertsy’s EmbryoInsights™ AI embryo assessment system now stands on an internationally recognized foundation of quality management in its mission to help improve embryo implantation and clinical pregnancy success rates. For reproductive medicine centers, adopting this system is equivalent to choosing an intelligent tool refined by rigorous international standards, ensuring a systematic enhancement in the precision and consistency of assessment processes.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Driving quality through international standards and safeguarding the origins of life with intelligent technology—by passing ISO 9001 certification for its software development quality management system, Fertsy has injected a stronger “AI + Quality” dual engine into the field of reproductive medicine, paving a more reliable technological path for countless families to realize their dream of having children.\u003C\u002Fp>\n\n\n\u003Cp class=\"wp-block-paragraph\">With quality as its guiding principle, Fertsy will continue to lead the intelligent transformation of assisted reproduction with the highest standards.\u003C\u002Fp>","https:\u002F\u002Fshengshengyi.com\u002Fwp-content\u002Fuploads\u002F2025\u002F08\u002F软件ISO9001-EN-Banner.png",[18],[],"Fertsy’s Quality Management System for Application","Fertsy’s Quality Management System for Application | Fertsy","Fertsy’s Quality Management System for Application: explore the clinical context, key developments, and Fertsy’s work in AI-assisted reproduction and IVF…",{"id":127,"date":128,"date_gmt":129,"modified":130,"modified_gmt":131,"title":132,"excerpt":134,"content":135,"featured_image":137,"categories":138,"tags":139,"sort_order":20,"focus_keyphrase":140,"seo_title":141,"seo_description":142},14,"2025-08-09T11:46:14","2025-08-09T03:46:14","2026-08-13T14:37:47","2026-08-13T06:37:47",{"rendered":133},"Fertsy Signs Strategic Cooperation Agreement with Progenesis","\u003Cp>July 11, 2025 – Fertsy announces the formal signing of a strategic cooperation agreement with US-based Progenesis. The two sides will collaborate in depth globally on AI embryo analysis software and other cutting-edge pr\u003C\u002Fp>\n",{"rendered":136,"protected":15},"\u003Cp class=\"wp-block-paragraph\">July 11, 2025 – Fertsy announces the formal signing of a strategic cooperation agreement with US-based Progenesis. The two sides will collaborate in depth globally on AI embryo analysis software and other cutting-edge products, jointly promoting the intelligent development of assisted reproduction technology (ART).\u003C\u002Fp>\n\n\n\n\u003Cfigure class=\"wp-block-image size-large\">\u003Cimg loading=\"lazy\" decoding=\"async\" src=\"https:\u002F\u002Fshengshengyi.com\u002Fwp-content\u002Fuploads\u002F2025\u002F07\u002Fimage-1024x436.png\" alt=\"\" class=\"wp-image-240 fertsy-content-image fertsy-content-image--wide\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" style=\"display:block;max-width:90%;width:90%;height:auto;aspect-ratio:1024 \u002F 436;object-fit:contain;margin:24px auto;\">\u003C\u002Ffigure>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Progenesis is one of the leaders in in vitro fertilization (IVF) genetic testing in the US and globally. With over 20 years of industry experience, the company serves more than 1,500 clinics worldwide and has helped over 100,000 families realize their fertility dreams. Progenesis enjoys a high reputation in the industry due to its advanced preimplantation genetic testing (PGT) technology and extensive global business network.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">According to the agreement, Progenesis will leverage its broad customer network in key markets such as the US, Brazil, and India to promote Fertsy’s flagship product, EmbryoInsights™ AI embryo analysis software. In addition, the two parties will actively explore deep integration at the product level and jointly conduct research cooperation on future-oriented ‘multimodal AI’ embryo assessment technology, aiming to provide more precise and efficient fertility solutions for patients worldwide.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Dr. Nabil Arrach, CEO of Progenesis, expressed high expectations for this collaboration, stating: \"I am very excited to work with Fertsy. Combining EmbryoInsights™’s cutting-edge AI technology with our expertise in genetic testing will bring a revolutionary breakthrough to embryo assessment. This will not only enhance the precision of our services, but more importantly, will bring new hope to tens of thousands of families worldwide, helping them realize the dream of having a healthy baby faster and more safely.\"\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">The collaboration with Progenesis is an important step in Fertsy’s ongoing globalization strategy. This marks a further deepening of our \"local agency + global cooperation\" two-pronged development model. Progenesis’s strong market coverage and industry reputation will provide strong support for our business expansion in key markets such as the Americas and South Asia, enabling our innovative technology to serve a broader population.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Progenesis was the most agile and quick among the many peers Fertsy met at the just-concluded European Society of Human Reproduction and Embryology (ESHRE) 2025 annual meeting. In the coming weeks and months, we can expect news of more global cooperation actions and deal closures. Such collaborations and deals will fully leverage the advantages of all parties in technology R&D and market channels, jointly committed to improving IVF success rates, reducing patient burdens, and leading the global assisted reproduction industry into a new era driven by AI.\u003C\u002Fp>\n\n\n\n\u003Ch4 class=\"wp-block-heading\">About Fertsy\u003C\u002Fh4>\n\n\n\n\u003Cfigure class=\"wp-block-image size-full\">\u003Cimg loading=\"lazy\" decoding=\"async\" src=\"https:\u002F\u002Fshengshengyi.com\u002Fwp-content\u002Fuploads\u002F2025\u002F08\u002F%E7%94%9F%E7%94%9F%E6%98%93.png\" alt=\"\" class=\"wp-image-366 fertsy-content-image fertsy-content-image--wide\" sizes=\"auto, (max-width: 630px) 100vw, 630px\" style=\"display:block;max-width:90%;width:90%;height:auto;aspect-ratio:630 \u002F 140;object-fit:contain;margin:24px auto;\">\u003C\u002Ffigure>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Fertsy is committed to using artificial intelligence and other innovative technologies to improve the success rate and accessibility of assisted reproduction, aiming to become a comprehensive solution provider for next-generation intelligent fertility centers.\u003C\u002Fp>\n\n\n\n\u003Ch4 class=\"wp-block-heading\">About Progenesis\u003C\u002Fh4>\n\n\n\n\u003Cfigure class=\"wp-block-image size-full\">\u003Cimg loading=\"lazy\" decoding=\"async\" src=\"https:\u002F\u002Fshengshengyi.com\u002Fwp-content\u002Fuploads\u002F2025\u002F07\u002Fimage-2.png\" alt=\"\" class=\"wp-image-205 fertsy-content-image fertsy-content-image--wide\" sizes=\"auto, (max-width: 698px) 100vw, 698px\" style=\"display:block;max-width:90%;width:90%;height:auto;aspect-ratio:698 \u002F 300;object-fit:contain;margin:24px auto;\">\u003C\u002Ffigure>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Progenesis is a globally leading genetic testing company, founded in 2015 and headquartered in San Diego, dedicated to providing non-invasive genetic testing services for patients in family planning. The company offers a variety of customized services to meet the needs of different patients. The Progenesis team consists of passionate geneticists, researchers, and laboratory professionals dedicated to improving patients’ lives. As a pioneer in genetic screening technology, Progenesis scientists continuously advance research to improve services and deepen the understanding of human genetics. \u003C\u002Fp>\u003Cp class=\"wp-block-paragraph\">They deeply understand the trust patients place in the health of their future children, and take this as their responsibility. All Progenesis tests utilize the latest, industry-leading molecular biology technologies to ensure the most accurate results. Its team has optimized next-generation sequencing technology for 24-chromosome aneuploidy (PGT-A, PGT-SR, PGT-M) and offers 12-hour rapid testing to support fresh embryo transfers. Progenesis adheres to the highest quality control standards in the laboratory and has obtained certifications from the College of American Pathologists (CAP) and the Clinical Laboratory Improvement Amendments (CLIA#05D2121237). \u003C\u002Fp>\u003Cp class=\"wp-block-paragraph\">Its customer support team works closely with IVF clinics to ensure patient information is shared securely and efficiently, and is committed to continuously providing high-quality services. The company has in-house genetic counselors available to provide consultations to patients at any time.\u003C\u002Fp>","https:\u002F\u002Fshengshengyi.com\u002Fwp-content\u002Fuploads\u002F2025\u002F07\u002Fpro.webp",[18],[],"Fertsy Signs Strategic Cooperation Agreement with","Fertsy Signs Strategic Cooperation Agreement | Fertsy","July 11, 2025 – Fertsy announces the formal signing of a strategic cooperation agreement with US-based Progenesis. The two sides will collaborate in depth…",{"id":144,"date":145,"date_gmt":146,"modified":147,"modified_gmt":148,"title":149,"excerpt":151,"content":152,"featured_image":154,"categories":155,"tags":156,"sort_order":20,"focus_keyphrase":157,"seo_title":158,"seo_description":159},1371,"2025-07-02T08:48:00","2025-07-02T00:48:00","2026-08-13T14:39:40","2026-08-13T06:39:40",{"rendered":150},"Fertsy Showcases AI Solutions at ESHRE 2025","\u003Cp>Fertsy will unveil its latest research results at the 41st Annual Meeting of the European Society of Human Reproduction and Embryology (ESHRE 2025). This meeting, together with the American Society for Reproductive Medic\u003C\u002Fp>\n",{"rendered":153,"protected":15},"\u003Cp class=\"wp-block-paragraph\">Fertsy will unveil its latest research results at the 41st Annual Meeting of the European Society of Human Reproduction and Embryology (ESHRE 2025). Together with the American Society for Reproductive Medicine (ASRM) Annual Meeting that Fertsy attended late last year, ESHRE is regarded as one of the world’s two leading reproductive medicine conferences. The exhibition and scientific sessions will be held from June 29 to July 2, 2025, at the Paris Expo Porte de Versailles in Paris, France. At the exhibition, Fertsy will fully showcase a range of AI-based solutions for fertility centers at Booth A011.\u003C\u002Fp>\n\n\n\n\u003Cfigure class=\"wp-block-image size-large\">\u003Cimg loading=\"lazy\" decoding=\"async\" src=\"https:\u002F\u002Fshengshengyi.com\u002Fwp-content\u002Fuploads\u002F2025\u002F10\u002Ff18710efab834cce5129781a2f5c3341-edited.jpg\" alt=\"\" class=\"wp-image-474 fertsy-content-image fertsy-content-image--wide\" sizes=\"auto, (max-width: 2560px) 100vw, 2560px\" style=\"display:block;max-width:90%;width:90%;height:auto;aspect-ratio:2560 \u002F 1440;object-fit:contain;margin:24px auto;\">\u003C\u002Ffigure>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Meanwhile, following review by the conference scientific committee, a research abstract titled “Generalization validation of an interpretable artificial intelligence embryo selection model: a Cross-Brand retrospective study,” co-authored by Fertsy and the Reproductive Medicine Center of Nanjing Drum Tower Hospital, has been accepted for presentation (Abstract No. P-095). This retrospective internal-external validation study confirms the consistency of embryo selection performance of Fertsy’s AI embryo assessment system, EmbryoInsights, across different brands of time-lapse imaging systems (Astec CCM-iBIS vs. Vitrolife EmbryoScope). The results show no significant difference in predictive performance between the two datasets. The study demonstrates that EmbryoInsights, as an interpretable AI system, can effectively adapt to differences in hardware and software across different clinical centers, providing consistent assessment outcomes.\u003C\u002Fp>\n\n\n\n\u003Cfigure class=\"wp-block-image size-large\">\u003Cimg loading=\"lazy\" decoding=\"async\" src=\"https:\u002F\u002Fshengshengyi.com\u002Fwp-content\u002Fuploads\u002F2025\u002F10\u002FIMG_20250630_180640-1-edited.jpg\" alt=\"\" class=\"wp-image-479 fertsy-content-image fertsy-content-image--wide\" sizes=\"auto, (max-width: 994px) 100vw, 994px\" style=\"display:block;max-width:90%;width:90%;height:auto;aspect-ratio:994 \u002F 559;object-fit:contain;margin:24px auto;\">\u003C\u002Ffigure>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">At the concurrent ESHRE 2025 exhibition, Fertsy showcased the latest advancements in EmbryoInsights™, its AI-powered embryo assessment tool, and CryoTrio™, the intelligent liquid nitrogen storage monitoring system. The booth warmly welcomed visitors from around the world, generating more than seventy client leads.\u003C\u002Fp>\n\n\n\n\u003Cfigure class=\"wp-block-image size-large\">\u003Cimg loading=\"lazy\" decoding=\"async\" src=\"https:\u002F\u002Fshengshengyi.com\u002Fwp-content\u002Fuploads\u002F2025\u002F10\u002F%E5%BE%AE%E4%BF%A1%E5%9B%BE%E7%89%87_2025-10-19_205917_874-edited.jpg\" alt=\"\" class=\"wp-image-476 fertsy-content-image fertsy-content-image--wide\" sizes=\"auto, (max-width: 2560px) 100vw, 2560px\" style=\"display:block;max-width:90%;width:90%;height:auto;aspect-ratio:2560 \u002F 1440;object-fit:contain;margin:24px auto;\">\u003C\u002Ffigure>","https:\u002F\u002Fshengshengyi.com\u002Fwp-content\u002Fuploads\u002F2025\u002F10\u002F微信图片_2025-10-19_205917_874-edited.jpg",[18],[],"Fertsy Showcases AI Solutions at ESHRE","Fertsy Showcases AI Solutions at ESHRE 2025 | Fertsy","ESHRE 2025: discover key developments, clinical context, and Fertsy’s progress in AI-assisted reproduction, IVF technology, and healthcare innovation.",{"id":161,"date":162,"date_gmt":163,"modified":164,"modified_gmt":165,"title":166,"excerpt":168,"content":169,"featured_image":171,"categories":172,"tags":173,"sort_order":20,"focus_keyphrase":89,"seo_title":90,"seo_description":174},91,"2025-06-23T18:19:15","2025-06-23T10:19:15","2026-08-13T14:39:48","2026-08-13T06:39:48",{"rendered":167},"[Paris Rendezvous] Fertsy AI+IVF Solutions Showcased at Global Reproductive Medicine Conference","\u003Cp>Fertsy will present its latest research findings at the 41st Annual Meeting of the European Society of Human Reproduction and Embryology (ESHRE 2025). This conference, together with the American Society for Reproductive \u003C\u002Fp>\n",{"rendered":170,"protected":15},"\u003Cp class=\"wp-block-paragraph\" data-pm-slice=\"0 0 []\" style=\"margin-bottom: 8px; text-align: left;\">Fertsy will present its latest research findings at the 41st Annual Meeting of the European Society of Human Reproduction and Embryology (ESHRE 2025). This conference, together with the American Society for Reproductive Medicine (ASRM) meeting that Fertsy participated in late last year, are recognized as the two leading global reproductive conferences. The exhibition and scientific sessions will take place from June 29 to July 2, 2025, at the Paris Expo Porte de Versailles in Paris, France. At the exhibition, our company will showcase a comprehensive range of AI technology solutions for assisted reproduction centers at Booth A011.\u003C\u002Fp>\n\n\n\n\u003Cfigure class=\"wp-block-image size-full\">\u003Cimg decoding=\"async\" class=\"rich_pages wxw-img js_insertlocalimg fertsy-content-image fertsy-content-image--wide\" data-imgfileid=\"100000564\" data-ratio=\"0.3351851851851852\" data-s=\"300,640\" data-src=\"https:\u002F\u002Fshengshengyi.com\u002Fwp-content\u002Fuploads\u002F2026\u002F07\u002Fwechat-wechat-link-4050de83b012546b100e5177-0-image-1.png\" data-type=\"png\" data-w=\"1080\" type=\"block\" src=\"https:\u002F\u002Fshengshengyi.com\u002Fwp-content\u002Fuploads\u002F2026\u002F07\u002Fwechat-wechat-link-4050de83b012546b100e5177-0-image-1.png\" style=\"display:block;max-width:90%;width:90%;height:auto;aspect-ratio:1 \u002F 0.335185;object-fit:contain;margin:24px auto;\">\u003C\u002Ffigure>\n\n\n\n\u003Cp class=\"wp-block-paragraph\" data-pm-slice=\"0 0 []\" style=\"margin-bottom: 8px; text-align: left;\">Meanwhile, following review by the conference scientific committee, an abstract co-authored by Fertsy and the Center for Reproductive Medicine of Nanjing Drum Tower Hospital, titled \"Generalization validation of an interpretable artificial intelligence embryo selection model: a Cross-Brand retrospective study\", has been accepted for presentation (Abstract Number: P-095). This retrospective internal and external validation study verified the consistency of our AI embryo assessment system, EmbryoInsights, in embryo selection performance across different brands of time-lapse imaging systems (Astec CCM-iBIS vs Vitrolife EmbryoScope). The results showed no significant difference in predictive performance between the two datasets. The study demonstrates that EmbryoInsights, as an interpretable AI system, can effectively adapt to the hardware and software differences between clinical centers and provide consistent assessment results.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\" data-pm-slice=\"0 0 []\" style=\"margin-bottom: 8px; text-align: left;\">We sincerely invite you to visit Booth A011 and experience our technology and products firsthand. You can also read the article on our official WeChat account to learn more about Fertsy and the conference details. Let us exchange ideas and jointly promote the innovation and development of assisted reproductive technology.\u003C\u002Fp>\n\n\n\n\u003Cfigure class=\"wp-block-image size-full\">\u003Cimg decoding=\"async\" class=\"rich_pages wxw-img js_insertlocalimg fertsy-content-image fertsy-content-image--wide\" data-imgfileid=\"100000556\" data-ratio=\"0.1702127659574468\" data-s=\"300,640\" data-src=\"https:\u002F\u002Fshengshengyi.com\u002Fwp-content\u002Fuploads\u002F2026\u002F07\u002Fwechat-wechat-link-4050de83b012546b100e5177-0-image-2.png\" data-type=\"png\" data-w=\"940\" type=\"block\" src=\"https:\u002F\u002Fshengshengyi.com\u002Fwp-content\u002Fuploads\u002F2026\u002F07\u002Fwechat-wechat-link-4050de83b012546b100e5177-0-image-2.png\" style=\"display:block;max-width:90%;width:90%;height:auto;aspect-ratio:1 \u002F 0.170213;object-fit:contain;margin:24px auto;\">\u003C\u002Ffigure>","https:\u002F\u002Fshengshengyi.com\u002Fwp-content\u002Fuploads\u002F2026\u002F07\u002Fwechat-wechat-link-4050de83b012546b100e5177-0-cover.jpg",[18],[],"Fertsy will present its latest research findings at the 41st Annual Meeting of the European Society of Human Reproduction and Embryology (ESHRE 2025). Thi…",{"id":176,"date":177,"date_gmt":178,"modified":179,"modified_gmt":180,"title":181,"excerpt":183,"content":184,"featured_image":186,"categories":187,"tags":188,"sort_order":20,"focus_keyphrase":189,"seo_title":190,"seo_description":191},95,"2025-06-06T16:43:41","2025-06-06T08:43:41","2026-08-13T14:40:25","2026-08-13T06:40:25",{"rendered":182},"CryoTrio™ Earns CE and FCC Dual Certification: Ensuring IVF Liquid Nitrogen Storage Safety to International Standards","\u003Cp>To address the increasing pressure of liquid nitrogen storage management (refer to our previous three articles: “Global Incident Analysis of IVF Liquid Nitrogen Cryostorage Management”, “Guardians of Life’s Temperature: \u003C\u002Fp>\n",{"rendered":185,"protected":15},"\u003Cp class=\"wp-block-paragraph\">To address the increasing pressure of liquid nitrogen storage management (refer to our previous three articles: \"Global Incident Analysis of IVF Liquid Nitrogen Cryostorage Management\", \"Guardians of Life’s Temperature: A Complete Analysis of IVF Liquid Nitrogen Tank Monitoring Technology\", and \"Guardians of the Source of Life: Comprehensive Intelligent Monitoring of IVF Liquid Nitrogen Storage\"), Fertsy Inc has designed and developed a new three-in-one AI monitoring system, CryoTrio™, within the existing equipment system and management processes of fertility centers.\u003C\u002Fp>\n\n\n\n\u003Cfigure class=\"wp-block-image\">\u003Cimg decoding=\"async\" src=\"https:\u002F\u002Fshengshengyi.com\u002Fwp-content\u002Fuploads\u002F2026\u002F07\u002Fwechat-wechat-link-bf3a738190feda36050827c0-0-image-1.jpg\" alt=\"\" class=\"fertsy-content-image fertsy-content-image--natural\" style=\"display:block;max-width:90%;width:auto;height:auto;object-fit:contain;margin:24px auto;\">\u003C\u002Ffigure>\n\n\n\n\u003Cp class=\"has-text-align-left wp-block-paragraph\">The CryoTrio™ AI monitoring system has successfully obtained EU CE certification and US FCC certification, indicating that the system meets international standards in safety and reliability. CE certification is a mandatory safety certification imposed by the European Union on products entering its market. FCC certification is a market access credential for the United States, primarily focusing on the safety certification of wireless transmission equipment; products that have not obtained FCC certification are prohibited from being sold in the United States. The system employs wireless data transmission, avoiding cable constraints and minimizing the impact on daily laboratory operations. These certifications not only demonstrate that the system complies with the market access requirements of Europe and the United States but also reflect its high reliability and safety in medical environment applications.\u003C\u002Fp>\n\n\n\n\u003Cfigure class=\"wp-block-image\">\u003Cimg decoding=\"async\" src=\"https:\u002F\u002Fshengshengyi.com\u002Fwp-content\u002Fuploads\u002F2026\u002F07\u002Fwechat-wechat-link-bf3a738190feda36050827c0-0-image-2.jpg\" alt=\"\" class=\"fertsy-content-image fertsy-content-image--natural\" style=\"display:block;max-width:90%;width:auto;height:auto;object-fit:contain;margin:24px auto;\">\u003C\u002Ffigure>\n\n\n\n\u003Cfigure class=\"wp-block-image\">\u003Cimg decoding=\"async\" src=\"https:\u002F\u002Fshengshengyi.com\u002Fwp-content\u002Fuploads\u002F2026\u002F07\u002Fwechat-wechat-link-bf3a738190feda36050827c0-0-image-3.png\" alt=\"\" class=\"fertsy-content-image fertsy-content-image--natural\" style=\"display:block;max-width:90%;width:auto;height:auto;object-fit:contain;margin:24px auto;\">\u003C\u002Ffigure>\n\n\n\n\u003Cp class=\"has-text-align-left wp-block-paragraph\">The CryoTrio™ intelligent liquid nitrogen storage monitoring system is currently deployed and operating stably at IVF Canada Fertility Clinic Toronto and Aspire Houston Fertility Institute. These clinical practice cases validate the system’s applicability in the international high-end medical market.\u003C\u002Fp>\n\n\n\u003Cfigure class=\"aligncenter wp-block-image size-full\">\u003Cimg decoding=\"async\" src=\"https:\u002F\u002Fshengshengyi.com\u002Fwp-content\u002Fuploads\u002F2026\u002F07\u002Fwechat-wechat-link-bf3a738190feda36050827c0-0-image-4.jpg\" alt=\"\" class=\"fertsy-content-image fertsy-content-image--natural\" style=\"display:block;max-width:90%;width:auto;height:auto;object-fit:contain;margin:24px auto;\">\u003Cfigcaption class=\"fertsy-content-caption\">\u003Cspan>\u003Cspan data-pm-slice=\"1 1 ["para",{"tagName":"p","attributes":{"style":"text-align: left; text-indent: 25.4pt; line-height: 150%; break-before: auto; break-after: auto; word-break: normal; direction: ltr;"},"namespaceURI":"http:\u002F\u002Fwww.w3.org\u002F1999\u002Fxhtml"},"node",{"tagName":"span","attributes":{"style":null},"namespaceURI":"http:\u002F\u002Fwww.w3.org\u002F1999\u002Fxhtml"}]\">Fertility Clinic Toronto\u003C\u002Fspan> \n\u003C\u002Fspan>\u003C\u002Ffigcaption>\u003C\u002Ffigure>\n\n\n\n\n\n\u003Cfigure class=\"aligncenter wp-block-image size-full\">\u003Cimg decoding=\"async\" src=\"https:\u002F\u002Fshengshengyi.com\u002Fwp-content\u002Fuploads\u002F2026\u002F07\u002Fwechat-wechat-link-bf3a738190feda36050827c0-0-image-5.jpg\" alt=\"\" class=\"fertsy-content-image fertsy-content-image--natural\" style=\"display:block;max-width:90%;width:auto;height:auto;object-fit:contain;margin:24px auto;\">\u003Cfigcaption class=\"fertsy-content-caption\">\u003Cspan>\u003Cspan data-pm-slice=\"1 1 ["para",{"tagName":"p","attributes":{"style":"text-align: left; text-indent: 25.4pt; line-height: 150%; break-before: auto; break-after: auto; word-break: normal; direction: ltr;"},"namespaceURI":"http:\u002F\u002Fwww.w3.org\u002F1999\u002Fxhtml"},"node",{"tagName":"span","attributes":{"style":null},"namespaceURI":"http:\u002F\u002Fwww.w3.org\u002F1999\u002Fxhtml"}]\">Aspire Houston Fertility Institute\u003C\u002Fspan> \n\u003C\u002Fspan>\u003C\u002Ffigcaption>\u003C\u002Ffigure>\n\n\n\n\n\n\n\u003Cp class=\"wp-block-paragraph\">CryoTrio™ liquid nitrogen storage monitoring system has successfully obtained CE\u002FFCC international certification, signifying that the product has reached international leading standards in safety and reliability. This important milestone lays a solid foundation for the system’s entry into high-end medical markets in Europe and the United States. In the future, our company will continue to use innovative technology to safeguard every embryo and protect the birth of new life.\u003C\u002Fp>","https:\u002F\u002Fshengshengyi.com\u002Fwp-content\u002Fuploads\u002F2026\u002F07\u002Fwechat-wechat-link-bf3a738190feda36050827c0-0-cover.jpg",[18],[],"IVF technology","CryoTrio™ Earns CE and FCC | Fertsy","To address the increasing pressure of liquid nitrogen storage management (refer to our previous three articles: “Global Incident Analysis of IVF Liquid Ni…",{"id":193,"date":194,"date_gmt":195,"modified":196,"modified_gmt":197,"title":198,"excerpt":200,"content":201,"featured_image":203,"categories":204,"tags":205,"sort_order":20,"focus_keyphrase":206,"seo_title":207,"seo_description":208},1244,"2024-10-30T11:52:20","2024-10-30T03:52:20","2026-08-13T14:41:10","2026-08-13T06:41:10",{"rendered":199},"Fertsy Exhibits at the 2024 ASRM Annual Meeting","\u003Cp>From October 19 to 23, 2024, the American Society for Reproductive Medicine (ASRM) Annual Meeting was held in Denver, Colorado. As one of the world’s largest meetings with the most significant academic influence and indu\u003C\u002Fp>\n",{"rendered":202,"protected":15},"\u003Cfigure class=\"wp-block-image size-full\">\u003Cimg decoding=\"async\" class=\"rich_pages wxw-img js_insertlocalimg fertsy-content-image fertsy-content-image--wide\" data-croporisrc=\"https:\u002F\u002Fmmbiz.qpic.cn\u002Fmmbiz_jpg\u002FIwt11MtibkfFMuoSIxxPV3tib8kX3Jr4BjJPiboVLekYaI2OFMunoUhib7P3WtQNXXHAEC7TyOSMT9Gd8kGFlf0jsw\u002F0?wx_fmt=jpeg&from=appmsg\" data-cropx1=\"0\" data-cropx2=\"1280\" data-cropy1=\"0\" data-cropy2=\"287.8892733564014\" data-imgfileid=\"100000280\" data-ratio=\"0.225\" data-s=\"300,640\" data-src=\"https:\u002F\u002Fshengshengyi.com\u002Fwp-content\u002Fuploads\u002F2026\u002F07\u002Fwechat-wechat-link-90604084a916725dda8b5694-0-image-1.jpg\" data-type=\"jpeg\" data-w=\"1080\" style=\"display:block;max-width:90%;width:90%;height:auto;aspect-ratio:1 \u002F 0.225;object-fit:contain;margin:24px auto;\" src=\"https:\u002F\u002Fshengshengyi.com\u002Fwp-content\u002Fuploads\u002F2026\u002F07\u002Fwechat-wechat-link-90604084a916725dda8b5694-0-image-1.jpg\">\u003C\u002Ffigure>\n\n\n\n\u003Cp class=\"wp-block-paragraph\" style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-size-adjust: none; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; color: rgb(0, 0, 0);\">From October 19 to 23, 2024, the American Society for Reproductive Medicine (ASRM) Annual Meeting was held in Denver, Colorado. As one of the world’s largest and most significant meetings in terms of academic influence and industry representation, ASRM attracts experts, scholars, doctors, embryologists, and practitioners from around the world, especially the Americas, each year.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">Fertsy, as a global leader and continuous innovator in assisted reproduction artificial intelligence, showcased its latest products, including the Embryo-Insights explainable AI embryo assessment software and the CryoTrio intelligent liquid nitrogen storage monitoring system, at the exhibition from the 21st to the 23rd. It presented cutting-edge assisted reproduction AI solutions to visitors from five continents.\u003C\u002Fp>\n\n\n\n\u003Cfigure class=\"wp-block-image size-full\">\u003Cimg decoding=\"async\" class=\"rich_pages wxw-img js_insertlocalimg fertsy-content-image fertsy-content-image--wide\" data-imgfileid=\"100000279\" data-ratio=\"0.4222222222222222\" data-s=\"300,640\" data-src=\"https:\u002F\u002Fshengshengyi.com\u002Fwp-content\u002Fuploads\u002F2026\u002F07\u002Fwechat-wechat-link-90604084a916725dda8b5694-0-image-2.png\" data-type=\"png\" data-w=\"1080\" style=\"display:block;max-width:90%;width:90%;height:auto;aspect-ratio:1 \u002F 0.422222;object-fit:contain;margin:24px auto;\" src=\"https:\u002F\u002Fshengshengyi.com\u002Fwp-content\u002Fuploads\u002F2026\u002F07\u002Fwechat-wechat-link-90604084a916725dda8b5694-0-image-2.png\">\u003C\u002Ffigure>\n\n\n\n\u003Cp class=\"wp-block-paragraph\" style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-size-adjust: none; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; color: rgb(0, 0, 0);\">During the meeting, renowned experts including Marcelle Cedars, professor at the University of California, San Francisco School of Medicine, and Barry Behr, professor at Stanford University School of Medicine, as well as guests from industry-leading companies such as Vitrolife, Cooper Surgical, Cook Medical, ESCO, and Astec, visited the Fertsy booth with strong interest to learn about the products, explore cooperation opportunities, and discuss industry development trends. Meanwhile, a large number of fertility center directors, embryologists, physicians, and medical device distributors from North America, South America, Asia, and Oceania visited the booth, bringing extensive cooperation information and product purchase intentions.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\">During the exhibition breaks, the team also participated in several dinners and events organized by the North American Chinese embryologist community, making many new friends. Mr. Liu Changping, an advisor at Fertsy and a member of the exhibition team, fully participated in and supported the entire exhibition event.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\" style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-size-adjust: none; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; color: rgb(0, 0, 0);\">Earlier this year, Fertsy first presented an abstract at the European Society of Human Reproduction and Embryology (ESHRE) annual meeting, and now has participated in the ASRM exhibition. Moving forward, Fertsy will continue to collaborate with global colleagues to accelerate innovation and industrial implementation, promoting the application of artificial intelligence technology in assisted reproduction.\u003C\u002Fp>\n\n\n\n\u003Cfigure class=\"wp-block-image size-full\">\u003Cimg decoding=\"async\" class=\"rich_pages wxw-img js_insertlocalimg fertsy-content-image fertsy-content-image--wide\" data-croporisrc=\"https:\u002F\u002Fmmbiz.qpic.cn\u002Fmmbiz_jpg\u002FIwt11MtibkfFMuoSIxxPV3tib8kX3Jr4BjzezGPAXDhczDiaDkrDeHceYzs2faaUPDnbylZ25eTgEAR8e5agCzVcA\u002F0?wx_fmt=jpeg&from=appmsg\" data-cropx1=\"0\" data-cropx2=\"1202.491349480969\" data-cropy1=\"265.74394463667824\" data-cropy2=\"569.1349480968859\" data-imgfileid=\"100000287\" data-ratio=\"0.2518518518518518\" data-s=\"300,640\" data-src=\"https:\u002F\u002Fshengshengyi.com\u002Fwp-content\u002Fuploads\u002F2026\u002F07\u002Fwechat-wechat-link-90604084a916725dda8b5694-0-image-3.jpg\" data-type=\"jpeg\" data-w=\"1080\" style=\"display:block;max-width:90%;width:90%;height:auto;aspect-ratio:1 \u002F 0.251852;object-fit:contain;margin:24px auto;\" src=\"https:\u002F\u002Fshengshengyi.com\u002Fwp-content\u002Fuploads\u002F2026\u002F07\u002Fwechat-wechat-link-90604084a916725dda8b5694-0-image-3.jpg\">\u003C\u002Ffigure>","https:\u002F\u002Fshengshengyi.com\u002Fwp-content\u002Fuploads\u002F2026\u002F07\u002Fwechat-wechat-link-90604084a916725dda8b5694-0-cover.jpg",[18],[],"Fertsy Exhibits at the 2024 ASRM","Fertsy Exhibits at the 2024 ASRM Annual Meeting | Fertsy","From October 19 to 23, 2024, the American Society for Reproductive Medicine (ASRM) Annual Meeting was held in Denver, Colorado. As one of the world’s larg…",{"id":210,"date":211,"date_gmt":212,"modified":213,"modified_gmt":214,"title":215,"excerpt":217,"content":218,"featured_image":220,"categories":221,"tags":222,"sort_order":20,"focus_keyphrase":223,"seo_title":224,"seo_description":225},880,"2024-07-12T15:57:33","2024-07-12T07:57:33","2026-08-13T15:05:55","2026-08-13T07:05:55",{"rendered":216},"Fertsy Presents Collaborative Research Findings at ESHRE 2024","\u003Cp>From the 8th to the 10th of this month, the results of a collaborative study between our company and the reproductive center of Nanjing Drum Tower Hospital were formally presented at the 2024 European Society of Human Re\u003C\u002Fp>\n",{"rendered":219,"protected":15},"\u003Ch2 class=\"wp-block-heading\">Research Presented at ESHRE 2024\u003C\u002Fh2>\n\n\n\u003Cp class=\"wp-block-paragraph\" style=\"margin-bottom: 24px;\">The 2024 ESHRE Annual Meeting took place in Amsterdam, the Netherlands, from the 8th to the 10th of this month. Fertsy and the reproductive center of Nanjing Drum Tower Hospital presented findings from their collaborative study.\u003C\u002Fp>\n\n\n\u003Cp class=\"wp-block-paragraph\" style=\"margin-bottom: 24px;\">The study used Fertsy’s AI embryo image analysis platform. It examined developmental features during the blastocyst stage and their relationship with transfer outcomes.\u003C\u002Fp>\n\n\n\u003Cp class=\"wp-block-paragraph\" style=\"margin-bottom: 24px;\">The findings identified two dynamic features associated with embryo outcomes. One was blastocyst diameter expansion rate, calculated as diameter change divided by expansion time. The other was the frequency of small spontaneous collapses. Both may serve as new quantitative features for assessing blastocyst quality.\u003C\u002Fp>\n\n\n\n\u003Cfigure class=\"wp-block-image size-full\">\u003Cimg decoding=\"async\" class=\"rich_pages wxw-img aligncenter fertsy-content-image fertsy-content-image--wide\" style=\"display:block;max-width:90%;width:90%;height:auto;aspect-ratio:1 \u002F 0.558382;object-fit:contain;margin:24px auto;\" src=\"https:\u002F\u002Fshengshengyi.com\u002Fwp-content\u002Fuploads\u002F2026\u002F07\u002Fwechat-ar2vqt359oykmfl5vi50pv5d5slcxn6cxtlfiunpvvaa9h6gnhy6m-noilcurpx5-0-image-1.png\" data-imgfileid=\"100000192\" data-ratio=\"0.5583815028901734\" data-src=\"https:\u002F\u002Fshengshengyi.com\u002Fwp-content\u002Fuploads\u002F2026\u002F07\u002Fwechat-ar2vqt359oykmfl5vi50pv5d5slcxn6cxtlfiunpvvaa9h6gnhy6m-noilcurpx5-0-image-1.png\" data-type=\"png\" data-w=\"865\">\u003C\u002Ffigure>\n\n\n\n\u003Ch2 class=\"wp-block-heading\">International Exchange and Collaboration\u003C\u002Fh2>\n\n\n\u003Cp class=\"wp-block-paragraph\" style=\"margin-bottom: 24px;\">Fertsy and the fertility center of Nanjing Drum Tower Hospital both sent representatives to the event. They exchanged ideas with experts from several countries.\u003C\u002Fp>\n\n\n\u003Cp class=\"wp-block-paragraph\" style=\"margin-bottom: 24px;\">More experts are recognizing the value of expansion rate as a dynamic feature. A report from Spain’s IVIMRA fertility center discussed the same indicator. It found a significant relationship with embryo ploidy and live birth rate.\u003C\u002Fp>\n\n\n\u003Cp class=\"wp-block-paragraph\" style=\"margin-bottom: 24px;\">These measurable features also demonstrate the value of interpretable artificial intelligence in assisted reproduction.\u003C\u002Fp>\n\n\n\u003Cp class=\"wp-block-paragraph\" style=\"margin-bottom: 24px;\">As AI technology develops and gains wider clinical use, embryologists may uncover more underlying patterns. These patterns could support better outcome prediction and embryo selection.\u003C\u002Fp>\n\n\n\n\u003Cfigure class=\"wp-block-image size-full\">\u003Cimg decoding=\"async\" class=\"rich_pages wxw-img aligncenter fertsy-content-image fertsy-content-image--wide\" style=\"display:block;max-width:90%;width:90%;height:auto;aspect-ratio:1 \u002F 0.755469;object-fit:contain;margin:24px auto;\" src=\"https:\u002F\u002Fshengshengyi.com\u002Fwp-content\u002Fuploads\u002F2026\u002F07\u002Fwechat-ar2vqt359oykmfl5vi50pv5d5slcxn6cxtlfiunpvvaa9h6gnhy6m-noilcurpx5-0-image-2.jpg\" data-src=\"https:\u002F\u002Fshengshengyi.com\u002Fwp-content\u002Fuploads\u002F2026\u002F07\u002Fwechat-ar2vqt359oykmfl5vi50pv5d5slcxn6cxtlfiunpvvaa9h6gnhy6m-noilcurpx5-0-image-2.jpg\" data-ratio=\"0.75546875\" data-type=\"png\" data-w=\"1280\" data-imgfileid=\"100000193\">\u003C\u002Ffigure>\n\n\n\n\u003Ch2 class=\"wp-block-heading\">Connecting with the Global ART Community\u003C\u002Fh2>\n\n\n\u003Cp class=\"wp-block-paragraph\" style=\"margin-bottom: 24px;\">A large industry exhibition took place alongside the annual meeting. It brought together companies, institutions, and users from the global assisted reproduction sector. The exhibition gave us an important view of the global market. We believe Fertsy’s innovative products can reach more international users through this platform.\u003C\u002Fp>\n\n\n\n\u003Cfigure class=\"wp-block-image size-full\">\u003Cimg decoding=\"async\" class=\"rich_pages wxw-img aligncenter fertsy-content-image fertsy-content-image--wide\" style=\"display:block;max-width:90%;width:90%;height:auto;aspect-ratio:1 \u002F 0.562037;object-fit:contain;margin:24px auto;\" src=\"https:\u002F\u002Fshengshengyi.com\u002Fwp-content\u002Fuploads\u002F2026\u002F07\u002Fwechat-ar2vqt359oykmfl5vi50pv5d5slcxn6cxtlfiunpvvaa9h6gnhy6m-noilcurpx5-0-image-3.jpg\" data-src=\"https:\u002F\u002Fshengshengyi.com\u002Fwp-content\u002Fuploads\u002F2026\u002F07\u002Fwechat-ar2vqt359oykmfl5vi50pv5d5slcxn6cxtlfiunpvvaa9h6gnhy6m-noilcurpx5-0-image-3.jpg\" data-ratio=\"0.562037037037037\" data-s=\"300,640\" data-type=\"jpeg\" data-w=\"1080\" data-imgfileid=\"100000198\">\u003C\u002Ffigure>","https:\u002F\u002Fshengshengyi.com\u002Fwp-content\u002Fuploads\u002F2026\u002F07\u002Fwechat-ar2vqt359oykmfl5vi50pv5d5slcxn6cxtlfiunpvvaa9h6gnhy6m-noilcurpx5-0-cover.jpg",[18],[],"Fertsy Presents Collaborative Research Findings at","ESHRE 2024 | Fertsy","ESHRE 2024: discover key developments, clinical context, and Fertsy’s progress in AI-assisted reproduction, IVF technology, and healthcare innovation.",{"id":227,"date":228,"date_gmt":229,"modified":230,"modified_gmt":231,"title":232,"excerpt":234,"content":235,"featured_image":237,"categories":238,"tags":239,"sort_order":20,"focus_keyphrase":89,"seo_title":90,"seo_description":240},884,"2024-05-24T15:56:00","2024-05-24T07:56:00","2026-08-13T14:42:38","2026-08-13T06:42:38",{"rendered":233},"Fertsy’s Joint Research Findings Presented at the 7th Jiangsu Reproductive Medicine Conference","\u003Cp>Hosted by Jiangsu Medical Association and its Reproductive Medicine Branch, and organized by Nanjing Maternal and Child Health Hospital, the 7th Reproductive Medicine Academic Conference of Jiangsu Medical Association wa\u003C\u002Fp>\n",{"rendered":236,"protected":15},"\u003Cp class=\"wp-block-paragraph\" style=\"margin-bottom: 24px;\">Hosted by Jiangsu Medical Association and its Reproductive Medicine Branch, and organized by Nanjing Maternal and Child Health Hospital, the 7th Reproductive Medicine Academic Conference of Jiangsu Medical Association was grandly held in Nanjing from May 24 to 26, 2024. The conference invited numerous well-known domestic experts and scholars to give academic presentations, with multiple parallel sessions including Clinical, IVF Clinical Thinking Youth Forum, Laboratory and General, and Young Scholar Exchange, featuring brilliant academic exchanges on hot topics and challenges in the reproductive field.\u003C\u002Fp>\n\n\n\n\u003Cfigure class=\"wp-block-image size-full\">\u003Cimg decoding=\"async\" class=\"rich_pages wxw-img js_insertlocalimg fertsy-content-image fertsy-content-image--wide\" style=\"display:block;max-width:90%;width:90%;height:auto;aspect-ratio:1 \u002F 0.75;object-fit:contain;margin:24px auto;\" src=\"https:\u002F\u002Fshengshengyi.com\u002Fwp-content\u002Fuploads\u002F2026\u002F07\u002Fwechat-ar2vqt359oykmfl5vi50pdsdvkhol5wina-eeukxosyzqkoeoyxcoqw9nwdjpdru-0-image-1.jpg\" data-imgfileid=\"100000185\" data-ratio=\"0.75\" data-s=\"300,640\" data-src=\"https:\u002F\u002Fshengshengyi.com\u002Fwp-content\u002Fuploads\u002F2026\u002F07\u002Fwechat-ar2vqt359oykmfl5vi50pdsdvkhol5wina-eeukxosyzqkoeoyxcoqw9nwdjpdru-0-image-1.jpg\" data-type=\"jpeg\" data-w=\"796\">\u003C\u002Ffigure>\n\n\n\n\u003Cp class=\"wp-block-paragraph\" style=\"margin-bottom: 24px;\">The Obstetrics and Reproductive Medicine Center of Nanjing Drum Tower Hospital, affiliated with Nanjing University Medical School, was invited to present at this annual meeting the results of a joint research project with our company: \"A Clinical Study on Automatic Prediction of Pregnancy Outcomes of Fresh Cycle Single Blastocyst Transfer Using an Artificial Intelligence Model Based on Day 5 Interpretable Developmental Parameters.\" This study addressed the limitations of Day 5 morphological evaluation criteria in actual embryo assessment processes, utilizing time-lapse imaging and our proprietary AI platform to analyze and detect phenomena such as spontaneous collapse and expansion of blastocysts, and predicted blastocyst transfer outcomes based on quantified measurements and machine learning algorithms. Compared with traditional manual morphological assessment, the new model showed significantly improved predictive performance. This research has considerable potential clinical value in enhancing blastocyst assessment efficacy and further increasing the success rate of single blastocyst transfer.\u003C\u002Fp>\n\n\n\n\u003Cfigure class=\"wp-block-image size-full\">\u003Cimg decoding=\"async\" class=\"rich_pages wxw-img aligncenter fertsy-content-image fertsy-content-image--wide\" style=\"display:block;max-width:90%;width:90%;height:auto;aspect-ratio:1 \u002F 0.750509;object-fit:contain;margin:24px auto;\" src=\"https:\u002F\u002Fshengshengyi.com\u002Fwp-content\u002Fuploads\u002F2026\u002F07\u002Fwechat-ar2vqt359oykmfl5vi50pdsdvkhol5wina-eeukxosyzqkoeoyxcoqw9nwdjpdru-0-image-2.jpg\" data-src=\"https:\u002F\u002Fshengshengyi.com\u002Fwp-content\u002Fuploads\u002F2026\u002F07\u002Fwechat-ar2vqt359oykmfl5vi50pdsdvkhol5wina-eeukxosyzqkoeoyxcoqw9nwdjpdru-0-image-2.jpg\" data-ratio=\"0.7505091649694501\" data-s=\"300,640\" data-type=\"jpeg\" data-w=\"982\" data-imgfileid=\"100000184\">\u003C\u002Ffigure>\n\n\n\n\u003Cfigure class=\"wp-block-image size-full\">\u003Cimg decoding=\"async\" class=\"rich_pages wxw-img aligncenter fertsy-content-image fertsy-content-image--wide\" style=\"display:block;max-width:90%;width:90%;height:auto;aspect-ratio:1 \u002F 0.750251;object-fit:contain;margin:24px auto;\" src=\"https:\u002F\u002Fshengshengyi.com\u002Fwp-content\u002Fuploads\u002F2026\u002F07\u002Fwechat-ar2vqt359oykmfl5vi50pdsdvkhol5wina-eeukxosyzqkoeoyxcoqw9nwdjpdru-0-image-3.jpg\" data-src=\"https:\u002F\u002Fshengshengyi.com\u002Fwp-content\u002Fuploads\u002F2026\u002F07\u002Fwechat-ar2vqt359oykmfl5vi50pdsdvkhol5wina-eeukxosyzqkoeoyxcoqw9nwdjpdru-0-image-3.jpg\" data-ratio=\"0.7502507522567703\" data-s=\"300,640\" data-type=\"jpeg\" data-w=\"997\" data-imgfileid=\"100000183\">\u003C\u002Ffigure>","https:\u002F\u002Fshengshengyi.com\u002Fwp-content\u002Fuploads\u002F2026\u002F07\u002Fwechat-ar2vqt359oykmfl5vi50pdsdvkhol5wina-eeukxosyzqkoeoyxcoqw9nwdjpdru-0-cover.jpg",[18],[],"Hosted by Jiangsu Medical Association and its Reproductive Medicine Branch, and organized by Nanjing Maternal and Child Health Hospital, the 7th Reproduct…",{"id":242,"date":243,"date_gmt":244,"modified":245,"modified_gmt":246,"title":247,"excerpt":249,"content":250,"featured_image":252,"categories":253,"tags":254,"sort_order":20,"focus_keyphrase":106,"seo_title":255,"seo_description":256},1242,"2024-01-05T15:08:53","2024-01-05T07:08:53","2026-08-13T14:43:04","2026-08-13T06:43:04",{"rendered":248},"Fertsy Raises Several Million Yuan in Angel Round to Advance AI-Assisted Reproduction","\u003Cp>Recently, Fertsy Inc announced the completion of an angel round of financing worth several million RMB, led by Xishan Angel Club. This financing will be used to further promote the company’s R&\u003C\u002Fp>\n",{"rendered":251,"protected":15},"\u003Cp class=\"wp-block-paragraph\" style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; color: rgb(0, 0, 0);\">Recently, Fertsy Inc announced the completion of an angel round of financing worth several million RMB, led by Xishan Angel Club. This financing will be used to further promote the company’s R&D innovation, market expansion, and team building in the field of AI-assisted reproduction.\u003C\u002Fp>\n\n\n\n\u003Cfigure class=\"wp-block-image size-full\">\u003Cimg decoding=\"async\" class=\"rich_pages wxw-img fertsy-content-image fertsy-content-image--wide\" data-galleryid=\"\" data-imgfileid=\"100000150\" data-ratio=\"0.2462962962962963\" data-s=\"300,640\" data-src=\"https:\u002F\u002Fshengshengyi.com\u002Fwp-content\u002Fuploads\u002F2026\u002F07\u002Fwechat-wechat-link-7b7c393c5eb58167107f0656-0-image-1.png\" data-type=\"png\" data-w=\"1080\" style=\"display:block;max-width:90%;width:90%;height:auto;aspect-ratio:1 \u002F 0.246296;object-fit:contain;margin:24px auto;\" src=\"https:\u002F\u002Fshengshengyi.com\u002Fwp-content\u002Fuploads\u002F2026\u002F07\u002Fwechat-wechat-link-7b7c393c5eb58167107f0656-0-image-1.png\">\u003C\u002Ffigure>\n\n\n\n\u003Cp class=\"wp-block-paragraph\" style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; color: rgb(0, 0, 0);\">Xishan Angel Club is a well-known early-stage investment institution in China, long focusing on technological innovation, with rich investment experience and resource integration capabilities. As an early investor in China’s first publicly listed AI medical company, Xishan Angel Club has numerous successful investment cases in the health and artificial intelligence sectors.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\" style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; color: rgb(0, 0, 0);\">Xishan Angel Club stated that Fertsy has clear technological advantages in the field of AI-assisted reproduction, and is gradually building a series of intelligent medical device hardware and software products for assisted reproduction, helping domestic and international fertility centers improve success rates and service accessibility, showing great potential in the transformation and development of assisted reproductive technology.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\" style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; color: rgb(0, 0, 0);\">We are deeply grateful for Xishan’s trust and support, and will seize this financing opportunity to accelerate our growth and create greater value in AI-assisted reproduction. We also look forward to collaborating with industry peers, both domestically and internationally, as well as upstream and downstream partners, to jointly drive technological innovation and development in the assisted reproduction field.\u003C\u002Fp>\n\n\n\n\u003Ch2>About Fertsy Inc:\u003C\u002Fh2>\n\n\n\n\u003Cp class=\"wp-block-paragraph\" style=\"font-variant-numeric: normal; font-variant-east-asian: normal; font-variant-alternates: normal; font-kerning: auto; font-optical-sizing: auto; font-feature-settings: normal; font-variation-settings: normal; font-variant-position: normal; color: rgb(0, 0, 0);\">Fertsy Inc was founded in 2023 and is a startup dedicated to improving the success rate and accessibility of assisted reproduction. Leveraging new technologies such as artificial intelligence, robotics, and advanced manufacturing, it is building a new generation of assisted reproduction laboratories.\u003C\u002Fp>","https:\u002F\u002Fshengshengyi.com\u002Fwp-content\u002Fuploads\u002F2026\u002F07\u002Fwechat-wechat-link-7b7c393c5eb58167107f0656-0-cover.jpg",[18],[],"Fertsy Raises Several Million Yuan | Fertsy","Recently, Fertsy Inc announced the completion of an angel round of financing worth several million RMB, led by Xishan Angel Club. This financing will be u…",{"id":258,"date":259,"date_gmt":260,"modified":261,"modified_gmt":262,"title":263,"excerpt":265,"content":266,"featured_image":268,"categories":269,"tags":270,"sort_order":20,"focus_keyphrase":271,"seo_title":272,"seo_description":273},1232,"2023-10-16T18:08:28","2023-10-16T10:08:28","2026-08-13T14:43:50","2026-08-13T06:43:50",{"rendered":264},"Results of China’s First Prospective Clinical Study on AI-Assisted Embryo Selection Published","\u003Cp>A clinical study conducted in collaboration between Fertsy and the Reproductive Medicine Center of Nanjing Drum Tower Hospital was recently officially published in the journal Reproductive BioMedicine Online (RMBO). This\u003C\u002Fp>\n",{"rendered":267,"protected":15},"\u003Cp class=\"wp-block-paragraph\" style=\"color: rgb(0, 0, 0); margin-bottom: 24px;\">A clinical study conducted in collaboration between Fertsy and the Reproductive Medicine Center of Nanjing Drum Tower Hospital was recently officially published in the journal Reproductive BioMedicine Online (RMBO). This study is the first prospective clinical study on AI-assisted embryo selection published in China.\u003C\u002Fp>\n\n\n\n\u003Cfigure class=\"wp-block-image size-full\">\u003Cimg decoding=\"async\" class=\"rich_pages wxw-img fertsy-content-image fertsy-content-image--wide\" data-ratio=\"0.5046296296296297\" data-s=\"300,640\" data-src=\"https:\u002F\u002Fshengshengyi.com\u002Fwp-content\u002Fuploads\u002F2026\u002F07\u002Fwechat-ar2vqt359oykmfl5vi50pb4drplf1gqxn3kat2hc3rn9bk86wfykiy8untbv8svg-0-image-1.png\" data-type=\"png\" data-w=\"1080\" style=\"display:block;max-width:90%;width:90%;height:auto;aspect-ratio:1 \u002F 0.50463;object-fit:contain;margin:24px auto;\" src=\"https:\u002F\u002Fshengshengyi.com\u002Fwp-content\u002Fuploads\u002F2026\u002F07\u002Fwechat-ar2vqt359oykmfl5vi50pb4drplf1gqxn3kat2hc3rn9bk86wfykiy8untbv8svg-0-image-1.png\">\u003C\u002Ffigure>\n\n\n\n\u003Ch2>Prospective Controlled Trial\u003C\u002Fh2>\n\n\n\n\u003Cp class=\"wp-block-paragraph\" style=\"color: rgb(0, 0, 0); margin-bottom: 24px;\">The study included 350 single blastocyst transfer cases between 2021 and 2022, divided into an AI group and a manual group. In the AI group, blastocyst images captured under time-lapse microscopy were scored and ranked using an AI algorithm developed by Fertsy. The embryologist then selected the most promising blastocyst for transfer based on the system’s recommendations, and pregnancy and neonatal outcomes were tracked. The final results showed that, compared to traditional manual assessment, the clinical pregnancy rate in the AI group was significantly improved (68.15% vs. 80.87%, p=0.022), and the live birth rate increased from 62.22% to 70.43%.\u003C\u002Fp>\n\n\n\n\u003Ch2>Innovative explainable AI model\u003C\u002Fh2>\n\n\n\n\u003Cp class=\"wp-block-paragraph\" style=\"color: rgb(0, 0, 0); margin-bottom: 24px;\">Traditional black-box AI models face numerous challenges in clinical application due to the difficulty of explaining their reasoning processes. To address this issue, Fertsy has proposed an explainable AI embryo selection algorithm framework in the field of assisted reproduction. This framework is based on established medical consensus, uses deep learning technology to quantitatively measure multiple morphological indicators, and ultimately builds an embryo assessment system where both the process and the results are explainable.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\" style=\"color: rgb(0, 0, 0); margin-bottom: 24px;\">In recent years, the infertility rate among couples of childbearing age in China has been rising continuously, reaching 18% in first-tier cities, with 9.6 million infertile couples. Infertility has become a significant factor affecting China’s population issues. Although an increasing number of families are turning to assisted reproduction techniques, and the number of test-tube babies born annually in China has approached 400,000, with 3.7% of newborns being born through assisted reproduction, there is still considerable room to improve the success rate of this technology. \u003C\u002Fp>\u003Cp class=\"wp-block-paragraph\" style=\"color: rgb(0, 0, 0); margin-bottom: 24px;\">At the same time, there remains a significant imbalance in the technical level between different regions and different fertility centers, affecting the accessibility of this technology. The combination of artificial intelligence and assisted reproduction technology offers a solution to further improve the success rate and alleviate the shortage of high-quality medical resources. The integration of AI, automation, and biomedical technology is widely recognized as the future direction of assisted reproduction laboratories.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\" style=\"color: rgb(0, 0, 0); margin-bottom: 24px;\">The formal publication of this report is the first to demonstrate, through a prospective comparative trial, that an AI system can more accurately select embryos and improve the success rate of assisted reproduction. On the other hand, it also validates the concept of the explainable AI system proposed and developed by our company. During this study, the system worked closely with embryologists, helping them make more objective and accurate judgments. The publication of the research report has laid a solid foundation for the promotion and further optimization of this system. Our company will also promote more scientific research collaborations and continue to explore and broaden the possibilities of AI technology in the field of assisted reproduction.\u003C\u002Fp>\n\n\n\n\u003Ch2>About Fertsy Inc\u003C\u002Fh2>\n\n\n\n\u003Cp class=\"wp-block-paragraph\" style=\"color: rgb(0, 0, 0); margin-bottom: 24px;\">Fertsy is a high-tech company focused on intelligent assisted reproduction laboratory solutions. With a strong R&D team, it is dedicated to applying artificial intelligence, microfluidics, robotics, and other technologies to assisted reproduction laboratories to improve the success rate of assisted reproduction and help more families experience the joy of new life.\u003C\u002Fp>\n\n\n\n\u003Ch2>About the Reproductive Center of Nanjing Drum Tower Hospital\u003C\u002Fh2>\n\n\n\n\u003Cp class=\"wp-block-paragraph\" style=\"color: rgb(0, 0, 0); margin-bottom: 24px;\">The Reproductive Medicine Center of Nanjing Drum Tower Hospital was established in 2001. It is one of the specialty departments of obstetrics and gynecology and was among the first five institutions approved by the former Ministry of Health to carry out human assisted reproduction technologies. It is also one of the 13 institutions approved by the National Health and Family Planning Commission to conduct the clinical application pilot of preimplantation genetic diagnosis (PGD) using high-throughput gene sequencing. Additionally, it is a Key Specialty of Maternal and Child Health in Jiangsu Province and a Reproductive Medicine Innovation Team under Jiangsu Province’s ’12th Five-Year Plan for Science and Education Revitalizing Health’ project. The center routinely performs a series of assisted reproduction techniques, including intrauterine insemination, in vitro fertilization-embryo transfer, intracytoplasmic sperm injection, gamete and embryo cryopreservation, preimplantation genetic diagnosis\u002Fscreening, and in vitro maturation of immature oocytes.\u003C\u002Fp>","https:\u002F\u002Fshengshengyi.com\u002Fwp-content\u002Fuploads\u002F2026\u002F07\u002Fwechat-ar2vqt359oykmfl5vi50pb4drplf1gqxn3kat2hc3rn9bk86wfykiy8untbv8svg-0-cover.jpg",[18],[],"AI embryo selection","AI embryo selection | Fertsy","A clinical study conducted in collaboration between Fertsy and the Reproductive Medicine Center of Nanjing Drum Tower Hospital was recently officially pub…",{"id":275,"date":276,"date_gmt":277,"modified":278,"modified_gmt":279,"title":280,"excerpt":282,"content":283,"featured_image":285,"categories":286,"tags":287,"sort_order":20,"focus_keyphrase":271,"seo_title":90,"seo_description":288},1230,"2023-02-27T18:06:04","2023-02-27T10:06:04","2026-08-13T14:44:55","2026-08-13T06:44:55",{"rendered":281},"First Report of Fertsy’s AI Embryo Assessment System Clinical Trial at a Reproductive Medicine Conference","\u003Cp>On February 26–27, the 6th Jiangsu Provincial Reproductive Medicine Academic Conference was held at the foot of Purple Mountain in Nanjing, the ancient capital of six dynasties.\u003C\u002Fp>\n",{"rendered":284,"protected":15},"\u003Cp class=\"wp-block-paragraph\" style=\"outline: 0px;max-width: 100%;visibility: visible;box-sizing: border-box !important;overflow-wrap: break-word !important;margin-bottom: 24px;\">On February 26–27, the 6th Jiangsu Provincial Reproductive Medicine Academic Conference was held at the foot of Purple Mountain in Nanjing, the ancient capital of six dynasties.\u003C\u002Fp>\n\n\n\n\u003Cfigure class=\"wp-block-image size-full\">\u003Cimg decoding=\"async\" class=\"rich_pages wxw-img fertsy-content-image fertsy-content-image--wide\" data-ratio=\"0.5703125\" data-s=\"300,640\" data-src=\"https:\u002F\u002Fshengshengyi.com\u002Fwp-content\u002Fuploads\u002F2026\u002F07\u002Fwechat-ar2vqt359oykmfl5vi50prrsx62ln96u0y-vtdmdc-0ebg-iew2b2qyeprtb6oey-0-image-1.png\" data-type=\"png\" data-w=\"1280\" style=\"display:block;max-width:90%;width:90%;height:auto;aspect-ratio:1 \u002F 0.570313;object-fit:contain;margin:24px auto;\" src=\"https:\u002F\u002Fshengshengyi.com\u002Fwp-content\u002Fuploads\u002F2026\u002F07\u002Fwechat-ar2vqt359oykmfl5vi50prrsx62ln96u0y-vtdmdc-0ebg-iew2b2qyeprtb6oey-0-image-1.png\">\u003C\u002Ffigure>\n\n\n\n\u003Cp class=\"wp-block-paragraph\" style=\"outline: 0px;max-width: 100%;visibility: visible;box-sizing: border-box !important;overflow-wrap: break-word !important;margin-bottom: 24px;\">At this academic conference, the Reproductive Medicine Center of Nanjing Drum Tower Hospital reported for the first time the results of a prospective clinical study conducted in collaboration with Fertsy.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\" style=\"outline: 0px;max-width: 100%;visibility: visible;box-sizing: border-box !important;overflow-wrap: break-word !important;margin-bottom: 24px;\">In this randomized controlled clinical trial conducted from 2021 to 2022, a total of 576 patients were enrolled, using single blastocyst transfer, and divided into a manual assessment group and an AI assessment group. The results showed that the clinical pregnancy rate for manually selected embryos was 69.03%; while the clinical pregnancy rate using Fertsy’s intelligent embryo assessment system was 81.04%, representing a significant improvement over the manual group. The results of this prospective study indicate that Fertsy’s AI embryo assessment system has surpassed existing manual assessment methods in terms of consistency and accuracy, and the product is ready for commercial deployment. It is expected to help fertility centers further improve the success rate of assisted reproduction treatment in the future, bringing hope to more patients.\u003C\u002Fp>\n\n\n\n\u003Cfigure class=\"wp-block-image size-full\">\u003Cimg decoding=\"async\" class=\"rich_pages wxw-img fertsy-content-image fertsy-content-image--wide\" data-ratio=\"0.74921875\" data-s=\"300,640\" data-src=\"https:\u002F\u002Fshengshengyi.com\u002Fwp-content\u002Fuploads\u002F2026\u002F07\u002Fwechat-ar2vqt359oykmfl5vi50prrsx62ln96u0y-vtdmdc-0ebg-iew2b2qyeprtb6oey-0-image-2.jpg\" data-type=\"jpeg\" data-w=\"1280\" style=\"display:block;max-width:90%;width:90%;height:auto;aspect-ratio:1 \u002F 0.749219;object-fit:contain;margin:24px auto;\" src=\"https:\u002F\u002Fshengshengyi.com\u002Fwp-content\u002Fuploads\u002F2026\u002F07\u002Fwechat-ar2vqt359oykmfl5vi50prrsx62ln96u0y-vtdmdc-0ebg-iew2b2qyeprtb6oey-0-image-2.jpg\">\u003C\u002Ffigure>\n\n\n\n\u003Cp class=\"wp-block-paragraph\" style=\"outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;margin-bottom: 24px;\">The detailed results of this experiment (including neonatal data such as live birth rates) will be presented and analyzed in detail in a subsequent publication.\u003C\u002Fp>\n\n\n\n\u003Cp class=\"wp-block-paragraph\" style=\"outline: 0px;max-width: 100%;box-sizing: border-box !important;overflow-wrap: break-word !important;margin-bottom: 24px;\">At this conference, many other leading experts also reported on the latest advances in the application of artificial intelligence technology in assisted reproduction, both domestically and internationally. We believe that with the joint efforts of colleagues, as these technologies continue to be integrated and developed in the field of assisted reproduction, IVF laboratories will gradually become intelligent and automated, thereby greatly improving various indicators and success rates of the IVF process, and contributing to the treatment of infertility and global population issues.\u003C\u002Fp>\n\n\n\n\u003Cfigure class=\"wp-block-image size-full\">\u003Cimg decoding=\"async\" data-src=\"https:\u002F\u002Fshengshengyi.com\u002Fwp-content\u002Fuploads\u002F2026\u002F07\u002Fwechat-ar2vqt359oykmfl5vi50prrsx62ln96u0y-vtdmdc-0ebg-iew2b2qyeprtb6oey-0-image-3.jpg\" class=\"rich_pages wxw-img fertsy-content-image fertsy-content-image--wide\" data-ratio=\"0.75\" data-s=\"300,640\" data-type=\"jpeg\" data-w=\"1280\" style=\"display:block;max-width:90%;width:90%;height:auto;aspect-ratio:1 \u002F 0.75;object-fit:contain;margin:24px auto;\" src=\"https:\u002F\u002Fshengshengyi.com\u002Fwp-content\u002Fuploads\u002F2026\u002F07\u002Fwechat-ar2vqt359oykmfl5vi50prrsx62ln96u0y-vtdmdc-0ebg-iew2b2qyeprtb6oey-0-image-3.jpg\">\u003C\u002Ffigure>","https:\u002F\u002Fshengshengyi.com\u002Fwp-content\u002Fuploads\u002F2026\u002F07\u002Fwechat-ar2vqt359oykmfl5vi50prrsx62ln96u0y-vtdmdc-0ebg-iew2b2qyeprtb6oey-0-cover.jpg",[18],[],"On February 26–27, the 6th Jiangsu Provincial Reproductive Medicine Academic Conference was held at the foot of Purple Mountain in Nanjing, the ancient ca…",1786842061987]